Upload
others
View
0
Download
0
Embed Size (px)
Citation preview
2016 Annual Report
HEA
RT 2 0 1 6
Our electrophysiology (EP) team was one of the first in Virginia to offer the world’s smallest leadless (wire-free) pacemaker that is implanted directly into the heart with a catheter. Our team of electrophysiologists and cardiothoracic surgeons continue to provide a unique comprehensive program to address cardiac rhythm disorders, such as atrial fibrillation. Our EP program is among the busiest in the country.
Our structural heart program remains one of the nation’s most successful transcatheter aortic valve replacement (TAVR) centers.
The cardiothoracic surgery program reached an important milestone with 50,000 open heart cases.
Cardiac research also continues to be an important focus. Our heart experts are actively participating in numerous studies. This gives patients access to the latest emerging technologies while simultaneously improving cardiac care.
We are committed to the provision of safe, effective and quality cardiac care for the best value. As we move toward the alignment of cardiac and vascular services within Sentara Healthcare, we will continue to provide comprehensive and innovative care to this unique population of patients.
We encourage you to learn more about our nationally recognized innovative programs and services highlighted in this year’s annual report.
Sincerely,
It is with great pleasure that we share the 2016 Sentara Heart Annual Report with you. We are exceptionally proud to highlight some of the accomplishments of cardiac services across all Sentara Heart locations.
In 2016, we marked the 10-year anniversary of the opening of Sentara Heart Hospital, the region’s only dedicated heart hospital. For the 16th consecutive year, Sentara Heart was listed as a top 50 heart program by U.S. News & World Report. We are proud of this achievement as our cardiac program vies against more than 5,000 hospital programs nationwide for this recognition, including the most prestigious academic medical centers in the country.
The Sentara Heart network of hospitals and cardiac services impacts all of the communities that we serve. The care we provide wouldn’t be possible without the collaborative efforts of our 28,000-plus team members. Our world-class heart specialists strive for excellence in quality, customer care and safety every day. Each Sentara Heart service continues to uphold our long-standing reputation for clinical distinction with a proven record of exceptional patient outcomes. Ten of our hospitals have been recognized by the American College of Cardiology Foundation’s National Cardiovascular Data Registry and the American Heart Association for their outstanding treatment of patients with acute myocardial infarction.
Our two regional councils ensure exceptional quality at more than 100 care sites across our health system. The councils’ oversight and national benchmarking allow our care teams to identify areas of improvement, implement timely action plans and share standardized best practices across all Sentara Heart locations. This focus fosters the highest possible care processes and appropriate cardiac programs at our hospitals and cardiac service sites.
In 2016, we expanded the successes of some of our most respected and sought-after cardiac care programs and innovations. These successes include, but are not limited to, the following:
Sentara Heart’s non-invasive testing program partnered with IBM Watson to analyze structured and unstructured medical information. This involvement put Sentara Heart at the leading edge of a digital revolution to seek innovative ways to improve patient care.
Sentara Heart
2016 Annual Report
Thomas Klevan, MD Medical Director Sentara Heart
Audrey Douglas-CookeVice PresidentSentara Heart Hospital
Ken Armstrong Senior Divisional Vice President Sentara Cardiac Service Line
2 0 1 6
1 6
3 0
3 5
1 5
2 4
4 6
4 0
2
1
5
6
5 0
5 2
6 0
6 3
5 5
5 8
2 6
3 2
2 0
3 8
2 1
Sentara Advanced Heart Failure Center
Sentara Heart Valve and Structural Disease Center
Sentara Aortic Center
Cardiac Nursing
Cardiac Education
Sentara Cardiovascular Research Institute
Glossary
Transferring a Patient to Sentara Heart
Sentara Heart Promise
Non-Invasive Cardiology
Cardiac and Cardiac Pulmonary Rehabilitation
Ornish Lifestyle Medicine Program
Interventional Cardiology
Electrophysiology Program
Cardiothoracic Surgery
Cardiac Anesthesiology
Vascular Program
Sentara Heart Arrhythmia Center
Welcome
Sentara Healthcare Overview
Sentara Heart Hospital
Sentara Heart Network
To view this report online, go to AnnualReport.SentaraHeart.com
Sentara RMH Medical CenterHarrisonburg, VA238 Beds
Sentara Virginia Beach General HospitalVirginia Beach, VA276 Beds
Sentara Williamsburg Regional Medical CenterWilliamsburg, VA145 Beds
28,000+ Members of the Team
More than 1,000 Quality Physicians and Advanced Practice Clinicians
12 Acute Care Hospitals
Advanced Imaging and Diagnostic Centers
Nursing and Assisted-Living Centers
Outpatient Care CentersPhysical Therapy Centers
Home Care and Hospice in Virginia and Northeastern North Carolina
Optima Health Plan Serving 450,000 Members
Sentara College of Health Sciences
Sentara Quality Care Network A Clinically Integrated Network
SENTARA HEALTHCARE
AT A GLANCE
VIRGINIA
Charlottesville
Harrisonburg Woodbridge
Williamsburg
Hampton
Norfolk
Suffolk
Elizabeth City, NC
South Boston Virginia Beach
Hampton Roads
Blue Ridge
Northern Virginia
North Carolina
South Boston
NORTH CAROLINA
One healthcare system with many doors, but a
shared commitment to quality care and creating
an extraordinary healthcare experience.
Sentara Princess Anne HospitalVirginia Beach, VA160 Beds
Sentara Healthcare
Sentara Norfolk General HospitalNorfolk, VA525 Beds
Sentara Northern Virginia Medical CenterWoodbridge, VA183 Beds
Sentara Obici HospitalSuffolk, VA 176 Beds
1 27 in Hampton Roads
1 in Northern Virginia
2 in the Blue Ridge Region
1 in South Boston
1 in Northeastern North Carolina
Acute Care Hospitals
Sentara Albemarle Medical Center Elizabeth City, NC182 Beds
Sentara CarePlex Hospital Hampton, VA224 Beds
Orthopaedic Hospital at Sentara CarePlex HospitalHampton, VA18 Beds (included in Sentara
CarePlex Hospital license)
Sentara Martha Jefferson HospitalCharlottesville, VA176 Beds
Sentara Heart Hospital Norfolk, VA 112 Beds (included in Sentara
Norfolk General Hospital license)
Sentara Leigh HospitalNorfolk, VA 250 Beds
Orthopedic Hospital at Sentara Leigh Hospital Norfolk, VA 48 beds
Sentara Halifax Regional HospitalSouth Boston, VA192 Beds
3SENTARA HEART
Staying Ahead
of the Curve
Our goal at Sentara is to be among the best healthcare providers in the country. We strive for top 10 percent rankings in all areas where care, quality and service are considered.
We’re proud that we have been recognized by many state and national organizations for our work, because it means that we are giving our patients the attention and help they deserve. From hybrid ORs to innovative physicians and advanced practice clinicians to new models of care, we’ve always been ahead of the curve.
Sentara provided $341,145,000 in Community Benefits in 2016
Sentara was FIRST in the nation to pioneer eICU®, a remote monitoring system for intensive care.
We performed Hampton Roads’ FIRST heart and kidney transplants, in addition to the FIRST open heartsurgery.
We were one of the FIRST health systems to join and provide data for the IBM Watson Health global initiative.
Sentara conducted the WORLD’S LARGEST clinical trial of copper- preventing health-care associated infections and we have copper-infused linens and hard surfaces in every hospital.
1 3 3,8 0 1Adult Hospital Admissions
7 9 0,2 2 3ER Visits
1 6,3 5 8 Deliveries
$ 310,123,000 $ 18,923,000 $ 12,099,000 $ 341,145,000
SENTARA HEART HOSPITAL
Recognized for more than 17 years as one of America’s best hospitals for Cardiology and Heart Surgery by U.S. News & World Report.
Sentara Heart includes more than 140 board-certified cardiologists,
cardiothoracic surgeons and anesthesiologists. From diagnostic testing
to emergency heart attack care, Sentara Hospitals provide quality heart
care to the residents of our service area and beyond. Because each
Sentara Hospital is part of the Sentara Heart network, each local heart
program shares innovative procedures, cutting-edge technologies and
best practices.
Our programs are accessible, located in convenient locations and
welcoming facilities throughout the community. This remarkable
delivery system is made possible through a sophisticated technology
infrastructure and a commitment to blending clinical teams with the
common goal of advancing patient care.
Our world-class heart specialists strive
for excellence in clinical quality, customer
centricity and medical innovation. Each
Sentara Heart service continues to
uphold our long-standing reputation for
clinical distinction with a proven record of
exceptional patient outcomes.”
— Ken Armstrong
Senior Divisional Vice President, Sentara Cardiac Service Line
5SENTARA HEART4
Sentara Heart Network
Sentara Heart boasts a strong network of cardiac care throughout its integrated
system. With the exception of heart surgery, all Sentara community hospitals provide
a range of heart services. Patients from throughout Virginia and North Carolina
can receive emergency heart care in the Sentara location closest to them and be
transferred by ground or air ambulance to Sentara Heart Hospital, Sentara Virginia
Beach General Hospital or Sentara RMH Medical Center for open heart surgery,
should they need this advanced care. The other Sentara hospitals offer a range of
heart services, from comprehensive diagnostic testing and diagnostic catheterization
to emergency interventional cardiology and rehabilitation, within the fully integrated
network of Sentara hospitals.
Cardiac Departments
Cardiac Medicine
Non-Invasive Cardiology
Diagnostic Cardiovascular Imaging: MR/CT
Preventive Cardiology & Rehabilitation
Clinical Cardiology
Invasive & Interventional Cardiology
Cardiac Electrophysiology and Pacing
Heart Arrhythmia
Team Members
Electrophysiologists
Diagnostic Cardiologists
General Cardiologists
Interventional Cardiologists
Cardiothoracic Surgeons
Vascular Surgeons
Cardiac Anesthesiologists
Advanced Practice Clinicians
Nurses
Infectious Disease Specialists
Intensivists
Pulmonologists
Endocrinologists
Nephrologists
Multispecialty Centers
Sentara Heart Valve and Structural
Disease Center
Sentara Heart Arrhythmia Center
Sentara Aortic Center
Sentara Cardiac Diabetes Center
Sentara CardiovascularResearch Institute
SCRI works collaboratively with local institutions,
government agencies and biomedical companies on nationally
and internationally recognized clinical research trials.
SA
MC
SCH
SHH SHRH SLH S
MJH
SN
VM
C SO
H SPAH SRMH
S
VBGH
SW
RM
C
Multispecialty Centers
Te
am Members
Ca
rdia
c D
ep
artm
en
ts
Sentara
Heart
Outpatient Campuses and Physician Offices
Sentara Cardiovascular Research Institute
Hospitals
12 acute care hospitals—seven
in Hampton Roads (Southeastern
Virginia), one in Northern Virginia,
two in the Blue Ridge region of
Virginia, one in Southern Virginia and
one in North Carolina.
Outpatient Campuses and Physician Offices
As an integrated healthcare system
throughout Virginia and North Carolina,
we operate more than 100 sites of care
and partner with local providers.
Neurologists
Hospitalists
Primary Care Physicians
RCES/RCIS Certified Clinicians
Quality Coordinators
Researchers
Navigators
Education Specialists
Transplant Coordinators
Perfusionists
CVT Technicians
Imaging Specialists
Cardiovascular Technologists
FULLY INTEGRATED
SYSTEM OF HEART CARE
SAMC–Sentara Albemarle Medical Center
SCH–Sentara CarePlex Hospital
SHH–Sentara Heart Hospital
SHRH–Sentara Halifax Regional Hospital
SLH–Sentara Leigh Hospital
SMJH–Sentara Martha Jefferson Hospital
SNVMC–Sentara Northern Virginia Medical Center
SOH–Sentara Obici Hospital
SPAH–Sentara Princess Anne Hospital
SRMH–Sentara RMH Medical Center
SVBGH–Sentara Virginia Beach General Hospital
SWRMC–Sentara Williamsburg Regional Medical Center
Hos
pita
l abb
revi
atio
n ke
y
Aortic Disease
Heart Failure, MCS & Transplantation
Structural Heart Disease
Thoracic Surgery
Cardiothoracic Surgery
Pulmonary Hypertension
Cardiac Observation
Sentara Advanced Heart Failure
Center (includes specialization
in pulmonary arterial
hypertension)
7SENTARA HEART6
Sentara RMH Medical CenterHarrisonburg, VA | 238 Beds
Sentara Virginia Beach General HospitalVirginia Beach, VA | 276 Beds
Sentara Princess Anne HospitalVirginia Beach, VA | 160 Beds
Sentara Northern Virginia Medical CenterWoodbridge, VA | 183 Beds
Sentara Obici HospitalSuffolk, VA | 176 Beds
Sentara Albemarle Medical Center Elizabeth City, NC | 182 Beds
Sentara CarePlex Hospital Hampton, VA | 224 Beds
Sentara Martha Jefferson HospitalCharlottesville, VA | 176 Beds
Sentara Heart Hospital Norfolk, VA | 114 Beds
Sentara Leigh HospitalNorfolk, VA | 250 Beds
Sentara Halifax Regional HospitalSouth Boston, VA | 192 Beds
Ornish Lifestyle Medicine
AdvancedProcedures
AdvancedProcedures
AdvancedProcedures
AdvancedProcedures
Cardiac SurgeryHeart
Transplant/ VAD
STEMI Receiving
CenterPCI Center
Catheter-Based Diagnostic
Center
Pacemaker/ICD Implants
ArrhythmiaAblations
Non-Invasive Diagnostic
Testing
Advanced Cardiovascular
Imaging
Structural Heart Program
Cardiac Rehab
Sentara Williamsburg Regional Medical CenterWilliamsburg, VA | 145 Beds
Sentara Heart Services
1
4
1 2
2
3
4
5
6
7
8
9
1 0
1 1
1 21 0 1 1
3
6
987
5
21
20
16
Se
nta
ra H
ea
rt V
olu
me
s
Cardiothoracic Surgeries
Interventional Cath Procedures
Electrophysiology Procedures(Ablation, AICDs and Pacers)
Diagnostic Cath Procedures
4,1 3 3
1 3,43 2
5,3 1 2
2,2 6 7
Non-Invasive Diagnostic Testing
(Echos, Stress Echos, Treadmill, Holter and Event Monitoring)1 0 2,47 3
Sentara Albemarle Medical Center (SAMC) in Elizabeth City, NC, joined
Sentara Healthcare in 2014. Sentara has provided care for North Carolina
residents at our hospitals in Virginia, but SAMC is the first Sentara hospital
actually located in the state.
In 2016, the hospital’s cardiac rehabilitation (cardiac rehab) program saw
a 40 percent increase in patient usage. This increase is attributed to the
rehab team’s dedication to educating patients about the importance of
making healthy lifestyle changes to improve heart health. Cardiac rehab
patients recovering from heart events and heart procedures participate in
physical activity under the close supervision of medical experts. SAMC staff
also reworked scheduling to open up more early morning and weekday
appointments often requested by older heart patients.
The cardiac rehab program at SAMC is accredited by the American
Association of Cardiovascular and Pulmonary Rehabilitation. The 182-bed
hospital also has echocardiography accreditation from the Intersocietal
Accreditation Commission and nuclear cardiology accreditation from the
American College of Radiology.
In 2016, the hospital welcomed the services of its first electrophysiologist.
Since then, more than 50 heart patients have received automatic implantable
cardioverter defibrillators (AICDs). These devices are similar to pacemakers,
delivering electrical shocks to the heart when needed. Approximately 130
other patients received different types of implantable devices in 2016.
The hospital excels at providing timely emergency cardiac care with an
average door-to-needle time of 28 minutes. This time refers to how long
Sentara Albemarle Medical Center
Electrophysiology Procedures(AICDs and Pacers)
Nuclear Stress Testing
Diagnostic Cath Procedures
MUGA Scans
13 0
8 8 6
3,22 7
9 5 6
1 5
Non-Invasive Diagnostic Procedures(Echos 2,540; Stress echos 78; treadmill 56; Zio patches 140; Holter
monitoring 89; event monitoring 0; TEE 208; tilt table 116)
2016 VolumesSentara Albemarle Medical Center
2016 V
olu
me
sS
enta
ra H
eart
Hos
pita
l
SPOTLIGHT
SENTARA
HEART PROGRAM
continued on p. 12
Cardiothoracic Surgeries
Interventional Cath Procedures
Electrophysiology Procedures(Ablation, AICDs and Pacers)
Diagnostic Cath Procedures
1,7 82
1,6 9 0
1,9 6 5
4,4 0 0Non-Invasive Diagnostic Testing
(Echos, Stress Echos, Treadmill, Holter and Event Monitoring)21,725 SENTARA HEART10 11
Sentara Halifax Regional Hospital
For more than 60 years, Sentara Halifax Regional Hospital (SHRH) in
South Boston, VA, has provided exceptional care to residents of
Virginia’s south central region and residents of the bordering state of
North Carolina. The Halifax hospital joined Sentara Healthcare in 2013.
In 2016, SHRH received the Quality Innovation Award given by the
Virginia Health Quality Center, a nonprofit health quality consulting
company that conducts studies of exemplary infection control and
customer service. Only hospitals that score in the top 10 percent of a
Centers for Disease Control and Prevention (CDC) assessment for
infection prevention receive this award.
The skilled cardiac team at SHRH provides state-of-the-art diagnostic
testing, including heart catheterizations, electrocardiography (EKG),
transesophageal echocardiography (TEE), exercise and
pharmacologic stress tests, Doppler echo studies, nuclear imaging,
tilt table testing, and Holter and event monitoring. Additional cardiac
services include interventional cardiology, implantable devices and
cardiac rehabilitation.
The cardiac rehabilitation program at SHRH is accredited by the
American Association of Cardiovascular and Pulmonary
Rehabilitation. The 192-bed hospital also has echocardiography
accreditation and nuclear cardiology accreditation from the
Intersocietal Accreditation Commission (IAC).
SHRH is a leader in providing timely emergency cardiac care and
boasts an average door-to-balloon time of 54 minutes. This time
refers to how long it takes cardiac catheterization lab staff to perform
a coronary interventional procedure, such as angioplasty, on a heart
attack patient after they enter the ED. In 2016, the hospital performed
more than 700 cardiac procedures, including 539 diagnostic cath
procedures, 105 interventional cath procedures and 95 implantable
devices such as pacemakers.
Cardiac experts at SHRH are active in a variety of community
outreach programs. Members of the community can sign up for a free
Pocket EKG cardiac screening. Cardiac teams use EKGs, bloodwork
and vital signs assessments to screen participants for signs of cardiac
distress. Participants then receive pocket-size, laminated cards with
the EKG screening results. SHRH teams also offer community-wide
free screenings for peripheral artery disease (PAD), also known as
hardening of the arteries.
SPOTLIGHT
SENTARA
HEART PROGRAM
Echos
Nuclear Stress
Diagnostic Cath
Pacemakers/ICDs
3,5 9 7
1,47 8
1,7 8 8
5 3 9
9 5
Interventional Cath Procedures
Non-Invasive Diagnostic Procedures (Treadmill 451; Holter monitoring 1,337)
1 0 5
2016 VolumesSentara Halifax Regional Hospital
it takes emergency department (ED) personnel to
administer clot-busting thrombolytic drugs to a heart
attack patient after they enter the ED.
State-of-the-art diagnostic testing services at SAMC
include heart catheterizations, electrocardiography (EKG),
exercise and pharmacologic stress tests, Doppler echo
studies, nuclear imaging, tilt table testing, and Holter
and event monitoring. In 2016, the hospital performed
approximately 938 catheterizations, with approximately
70 percent of the procedures done transradially through
the wrist.
SAMC also provides the community with quarterly
Pocket EKG cardiac screenings. Cardiac teams use EKGs,
bloodwork and vital signs testing to screen members
of the community for heart disease. Participants receive
pocket-size, laminated cards with the screening results
that they can carry in their wallets. Should a participant
develop a heart problem in the future, doctors can
compare this baseline EKG with future EKGs to aid in a
timely diagnosis.
continued from p. 11
13SENTARA HEART12
Average LOS—
Elective CABG patientsSource: Sentara Heart
10
8
6
4
2
0Sentara Heart Hospital (SNGH)
Top 10% Hospitals–6.9 DAYS
National Average–9.4 DAYS
Sentara Heart Promise
6.77
2016
O ne morning at work, 48-year-old
Julie Williams’ heart rate soared
from a normal 60 beats per
minute to 170 beats. Her accelerated heart
beat continued for nearly four hours and the
longer it lasted the more intensely fatigued
she became.
Although Julie had suffered from SVT (what
many describe as “heart flutters”) for more
than 20 years, she had never experienced
anything that frightening. She called her
primary care physician, Dr. Renee Fischer,
who referred her to the Sentara Martha
Jefferson Hospital Device Clinic for a Holter
monitor. Results from two weeks of constantly
monitoring Julie’s heart led Dr. Fischer to refer
her to cardiologist Dr. William Freedman.
The first plan of treatment for Julie was
medication management. However, the
medication proved ineffective in regulating her
heart rate. In the meantime, Julie didn’t have
the energy or strength to do many of her
PATIENT
Sentara Heart
Julie Williams
normal activities and hadn’t gardened for
weeks. Dr. Freedman referred Julie to
Dr. John Zakaib. Having just moved his
practice from the Cleveland Clinic to
Charlottesville, Dr. Zakaib was Martha
Jefferson’s newest electrophysiology (EP)
cardiologist. He has advanced training in the
treatment of atrial fibrillation.
After additional testing, Dr. Zakaib offered
Julie the answer to her heart problem: She
could take various medications for the rest of
her life to try and control it—
or he could cure it with a
procedure called ablation.
“I was nervous but my family
offered me a lot of support,” said
Julie. “We decided that if this
procedure could cure me, I had
to have it done.”
On October 10, 2008, Julie
underwent treatment in the
Sentara Martha Jefferson EP
procedural lab. With Julie
relaxed under the mild sedation
of Versed and Fentanyl, Dr.
Zakaib conducted diagnostic
tests to determine the cause of
her irregular heart rhythms.
He pinpointed a focal location in
the electrical system of Julie’s
heart that caused her arrhythmia.
He performed ablation, effectively stopping
the harmful impulses and terminating the
arrhythmia.
“I don’t have enough kind words to say about
Dr. Zakaib and the staff,” said Julie. “I was
emotional going into the surgery, but they
kept me as comfortable as possible. One
nurse even held my hand throughout the
entire procedure. I’d refer anyone having
problems like mine to Dr. Zakaib. I’m so glad
he’s at Martha Jefferson.”
From treatment to cure: Overcoming Afib
7.42
2015
Program Leads
Melissa Connolly, MSN, RN, ACNP-C
Amy Shannon, MSN, RN, FNP-C
Sentara Heart Promise offers a one-of-a-kind
support system that provides coordinated care
for better health before, during and after heart
surgery. Developed at Sentara Heart for coronary
artery bypass and valve replacement surgery
patients, Sentara Heart Promise provides:
• Pre-surgical screening, evaluation and
education
• Heart team approach to care
• Patient and family individualized plans of care
• Post-surgery follow-up care
• Preventive services and counseling
The program’s centerpiece is a unique, pre-
surgery assessment tool administered by nurse
practitioners to evaluate a patient’s health prior
to surgery. This clinical checklist is designed to
identify underlying conditions that could disrupt
scheduled surgery or complicate recovery.
Since the pilot was created in 2012, the program
has eliminated day of surgery cancellations
for cardiothoracic surgery patients and has
significantly reduced readmission rates.
Other major successes include:
• Streamlined, same-day appointments with
the Promise team and cardiac surgeons
• Identification of underlying conditions
prior to surgery, preventing complications
or surgery delays
• Collaboration with Endocrinology to
provide both pre- and postoperative
diabetes care
• Decreases in postoperative atrial
fibrillation, prolonged vent and
postoperative renal failure rates
• Decreased patient length of stay
• Decreased surgical cancellation rates
• Heart team approach, individualized risk
assessment shared with each patient
• Deliver medical approaches or other
alternative therapies to patients too high-
risk for surgery
• Streamlined pre- and post-surgical education
to ensure patients are well-informed about
their procedure without overwhelming them
with excessive materials
• Improved outcomes with a postoperative
recovery checklist that patients can easily
follow during their admission and at home
Sentara Heart Promise is led by advanced
practice clinicians who work with our elective,
outpatient population and our inpatient
preoperative population. Through this
program, every surgical patient has a point
of contact for the entire surgical timeline:
preoperatively, postoperatively and up to 30
to 90 days post discharge. 15SENTARA HEART14
Advanced Cardiovascular Imaging
• One of the fastest and most accurate cardiac CT
scanners in the region. It takes only five seconds—
or five heartbeats—for this 256-slice cardiac CT
scanner to create complete images of the heart and
surrounding arteries.
• An accredited Echo Lab that performs more than
1,000 echo studies every month. Extensively trained
registered sonographers perform echocardiograms,
which are then read the same day by a cardiologist.
The availability of 3D echocardiography aids surgical
decision making by enabling doctors to crop images
and providing more detailed views of structures. The
lab also performs 2D stress echocardiography and
transesophageal echocardiography.
• A comprehensive oncology clinic with the latest
technology for echocardiographic strain, a test of
myocardial function in patients undergoing
chemotherapy. This procedure, which is necessary for
early detection and quantification of myocardial
dysfunction, can help inform therapeutic decision
making. It is also useful for follow-up evaluations of
therapeutic results.
skilled, subspecialized doctors are using world-class technology to
usher in a new era in imaging characterized by incredibly fast and
accurate diagnosis of cardiovascular disease, chest pain, stroke, and
other life-threatening illnesses.
As enthusiastic supporters of a wide array of cardiac clinical research
studies, our echo team is perennially at the technological forefront
of cardiac imaging. Throughout the Sentara Heart Network, all echo
labs are fully accredited by ICAEL. Our accomplishments in
echocardiography—together with rapidly growing areas such as
percutaneous transcatheter aortic valve replacement and atrial
fibrillation ablation—are essential to the Sentara mission of improving
health every day.
To contact the Advanced Cardiovascular Imaging Program,
call (757) 388-8870.
Non-Invasive
Cardiology
Advanced Cardiovascular Imaging
Heart diagnosis has traditionally required catheterization, a
procedure that increases both cost and patient risk. Over the
last decade, pressure has mounted for faster and cheaper
diagnoses, with less aggravation to patients. The healthcare
community responded with dramatic improvements. Most
notable is advanced coronary computed tomography (CT)
scanning, an innovative tool doctors now use to non-
invasively detect or rule out heart problems in patients.
Advanced cardiovascular imaging at Sentara Heart Hospital,
Sentara Virginia Beach General Hospital and Sentara
Williamsburg Regional Medical Center perform the most
complex cardiovascular imaging within 150 miles. Our highly
16 SENTARA HEART 17
At present, IBM Watson Health allows for retrospective analysis only,
confirming and recording cases of aortic stenosis already diagnosed
by a cardiologist and ensuring the diagnosis is captured in appropriate
records. In the future, the goal is to improve the accuracy of heart
disease diagnosis by using artificial intelligence as a first set of eyes
on diagnostic imaging tests to identify what is normal and what is not.
For instance, IBM Watson Health will read an echocardiogram and
document any signs of aortic stenosis. A technician reviews the
echocardiogram and the computer system’s findings, noting any
additional problems. A cardiologist now has more information to
ensure an accurate reading of the study. The addition of IBM Watson
Health as a first step in imaging reading should improve accuracies
and efficiencies while allowing doctors to spend less time on clerical
paperwork and more time treating patients.
As IBM Watson becomes more proficient in reading echocardiograms,
it could be used to promote best practices in following early stage aortic
stenosis patients by identifying those patients who were overdue for
clinical follow-up or imaging studies and alerting the clinician, patient or
both. The system will be able to pull from a vast array of data, including
medical imaging, electronic medical records, radiology and pathology
reports, lab results, medical journals, research studies and clinical care
guidelines to identify potential problems and predict outcomes.
Sentara Heart will continue to collaborate with IBM Watson Health to
provide data that can teach the system how to identify signs of other
cardiovascular conditions, such as heart attacks, valve disorders,
cardiomyopathy (disease of the heart muscle) and deep vein
thrombosis. IBM Health also has plans to teach the system to read
breast and lung imaging for cancer detection.
IBM Watson Health
Sentara Heart continues to be a forerunner in the use of innovative
technologies to improve the health of cardiovascular patients. In 2016,
our non-invasive cardiology program contributed data from more than
3,000 heart echocardiograms to IBM Watson Imaging Clinical Review, a
$4 billion health technology initiative spearheaded by IBM Health.
IBM Watson made a splash in 2011 when the computing system bested
some well-known Jeopardy champions on television, taking home the
$1 million first-place prize. The system understands natural language
and reasoning and is able to learn over time.
Sentara Heart is a founding member and lead contributor to a
worldwide group of 24 health institutions collaborating with IBM Health
on this project. For our first endeavor, IBM Health used the information
we provided to teach a computing system, known as IBM Watson
Health, how to read echocardiograms and identify signs of a common
heart condition called aortic stenosis.
Up to 1.5 million Americans have aortic stenosis, a condition that
occurs when calcium deposits build up on the heart’s aortic valve. The
valve becomes stiff and doesn’t open properly, restricting blood flow to
the body and causing fatigue, shortness of breath, chest pain, dizziness
or fainting. The number of people with aortic stenosis continues to rise
as people live longer.
Currently, one of IBM Watson Health’s main contributions is ensuring
that diagnostic test information makes its way into a patient’s medical
records. IBM Watson Health minimizes the risk of this oversight by
reading every single file in a heart patient’s medical record to identify
new information that represents a change between a cardiologist’s
report and data that should carry through to other records, such as
electronic medical records, billing and insurance reports.
NON-INVASIVE CARDIOLOGY
19SENTARA HEART18
physical fitness programs and provides
counseling and education on a range of
topics, such as a heart-healthy diet, tobacco
cessation and stress management. Specialists
work one-on-one to help patients build
endurance and stamina so they can return
to the activities they love and improve their
heart health.
The cardiac rehab programs at 10 Sentara
hospitals are certified by the American
Association of Cardiovascular and Pulmonary
Rehabilitation. Two locations currently are
seeking certification. In 2016, Sentara cardiac
and pulmonary rehab programs expanded
their service offerings to include:
Tobacco cessation program: In 2016, the
registered nurses and exercise physiologists
Ornish Lifestyle Medicine™ Program
for Reversing Heart Disease
A whole foods, plant-based diet that’s naturally low in fat and refined carbohydrates
Moderate aerobic activity
Stress management
Psychosocial encouragement
via support groups
In 2016, on the campus of Sentara Princess Anne in Virginia Beach,
Sentara became the first and only provider in the state to offer patients
a clinically proven way to reverse heart disease. Nearly four decades
of research show that people who complete and stick with the Ornish
Lifestyle Medicine™ program can reverse the progression of coronary
artery disease and other chronic conditions. Program participants may
reduce their risk of heart attack, lower their need for medication and
avoid the need for serious cardiac interventions like bypass surgery.
Program Overview—Over nine weeks, the Ornish Lifestyle Medicine™ program focuses on four core
lifestyle components:
Cardiac rehabilitation (rehab) at Sentara
Heart is instrumental in a patient’s recovery
following a cardiac event, such as a heart
attack, valve surgery or heart transplant. All
12 Sentara hospitals offer cardiac rehab, while
nine locations also offer pulmonary rehab
for patients with chronic lung problems,
such as emphysema, interstitial lung disease
and chronic obstructive pulmonary disease
(COPD). These programs help thousands of
patients every year.
The Sentara cardiac rehab team, comprised
of a medical director, cardiac nurses, exercise
physiologists, registered dietitians and
other heart experts, guides patients through
on the cardiac rehab team at Sentara Heart
Hospital completed training to become
certified tobacco cessation counselors. These
experts are taking part in a pilot program
aimed at reducing hospital readmissions
for patients with congestive heart failure
and heart disease by helping them to quit
smoking. Tobacco cessation training and
certification will expand to cardiac rehab team
members at other hospital locations.
Yoga for a stronger heart: The cardiac rehab
programs at Sentara Heart Hospital, Sentara
Leigh Hospital and Sentara CarePlex Hospital
added cardiac yoga to their service offerings.
The classes are taught by a yoga instructor
who has special training and is certified to
work with cardiac patients. Research suggests
that yoga-based programs help those with
heart disease by lowering blood pressure,
reducing stress and improving respiratory
function and heart rate.
Music for better breathing: Music therapy
is now part of the pulmonary rehab service
offerings at Sentara Heart. Patients use
deep breathing techniques while singing
and humming to improve respiratory
function. Studies show that music therapy, in
conjunction with traditional therapies, reduces
disease symptoms and improves quality of
life and mental well-being in patients with
chronic lung diseases.
Cardiac and Pulmonary
Rehabilitation
1
2
3
4
SENTARA HEART20 21
Participants experienced a 300% improvement in blood
flow to the heart
After three years, 77% of people who had undergone
coronary intervention procedures avoided
revascularization with no increased frequency of
cardiac events
After one year, participants experienced a significant
decrease in the frequency of angina, or chest pain,
with almost 3/4 of participants having no chest pain, a
result comparable to what is typically achieved through
revascularization procedures like coronary artery bypass
Low-density lipoprotein (LDL, or bad) cholesterol
numbers dropped by almost 40%
Participants lost an average of 24 pounds
After one year, nearly 90% of people still use the
healthy habits they learned in the program
ORNISH LIFESTYLE MEDICINE PROGRAM
Groups of up to 15 people participate in twice-
weekly, four-hour sessions for a total of 72
hours. Sentara experts in stress management,
behavioral health, fitness and nutrition direct
and lead the sessions. A nurse case manager
coordinates care and monitors each participant
as they progress through the program.
Sentara began offering the program as a way
to help patients be more proactive about
their health. Other locations in the Sentara
network will introduce the program in the
near future. Medicare and many commercial
insurers cover program costs for qualified and
eligible members.
2 5% 3 6%
8%
decrease of
low-density
lipoprotein (LDL)
cholesterol
increase
of exercise
capacity
reduction of A1C levelssignificant decreases in both systolic
and diastolic blood pressure
Study findings about the program’s effects
are compelling:
Ornish Results at Sentara in 2016
In 2016, 56 Sentara patients enrolled in the Ornish Lifestyle Medicine™ program.
At program completion, participants experienced a:
Ornish Lifestyle Medicine at Sentara Princess Anne
For more information, call (757) 507-8820 or go to Ornish.SentaraHeart.com.22 23SENTARA HEART
NATIONAL GUIDELINES
9 0 minutes
or less
2014-2016 Interventional In-Hospital
Risk-Adjusted O/E Mortality RatioSource: Sentara Heart (Includes all Sentara hospitals except Sentara Albemarle Medical Center)
A ratio of less than 1.0 means that fewer patients died than expected based on the
performance of other hospitals as adjusted for patients with the same types and severity
of medical problems.
Total Number of Cath Labs in the SystemSTEMI Program
Sentara Heart is a recognized leader for expedited treatment of ST-
elevation myocardial infarction (STEMI) patients. American College of
Cardiology and American Heart Association national guidelines state
that hospitals treating STEMI patients with emergency PCI should
reliably achieve a door-to-balloon time of 90 minutes or less. As a
participating hospital in D2B: An Alliance for Quality™, Sentara Heart’s
median time of 60 minutes for door-to-balloon was well below average
in 2015.
1.0
0.8
0.6
0.4
0.2
0.0
1.2
Expected mortality for this patient population
53 MINUTES
Sentara Martha
Jefferson Hospital
55 MINUTES
Sentara Williamsburg
Regional Medical Center
61 MINUTES
Sentara Leigh Hospital
62 MINUTES
Sentara Northern Virginia
Medical Center
64.5 MINUTES
Sentara Norfolk General Hospital
67.5 MINUTES
Sentara CarePlex Hospital
Median Door-to-Balloon Time
Sentara STEMI Receiving
Centers
Interventional
Cardiology Sentara Heart Hospital provides a wide range of cardiac
interventional procedures to treat coronary artery disease. The
sooner a patient suffering from heart defects and disease gets
interventional care, the better their chances of survival and
complete recovery.
Each year, Sentara Heart performs more than 4,000 interventional
procedures across 22 catheterization laboratories (cath labs)
throughout the state of Virginia. These state-of-the-art cath labs
significantly reduce radiation exposure.
Our cardiac teams provide specialized interventional catheterization
for defects that have historically required open surgery, such as:
• Atrial septal defects
• Ventricular septal defects (VSD)—including implantation
of a muscular VSD device
• Patent foramen ovale
• Intracoronary stents
• Drug-eluting stents
• Atrial, valvuloplasty, and
percutaneous coronary
interventions
• Chronic total occlusion
60 MINUTES
Sentara RMH Medical Center
Sentara Virginia Beach
General Hospital
What does the O/E mortality ratio mean?
The observed-to-expected mortality outcome (O/E mortality ratio)
is a risk-adjusted measure of a hospital’s mortality (death) rate. Risk
adjustment takes into account how sick patients are upon entering the
hospital. The mortality observed-to-expected measure tells us how we
are performing on mortality relative to what is expected for our patients,
given a variety of complicating characteristics, including their age,
chronic conditions like diabetes or heart failure, or whether the patient
was transferred from another hospital or admitted as an emergency. An
O/E ratio less than 1.0 indicates better than expected outcomes and an
O/E ratio greater than 1.0 indicates poorer than expected outcomes. (For
example, an O/E ratio of 0.50 for mortality would mean that mortality
was only 50% of the expected value; conversely a mortality ratio of 1.50
means that mortality was 150% of expected or 50% higher than expected.)
Sentara Albemarle Medical Center
Sentara CarePlex Hospital
Sentara Heart Hospital
Sentara Halifax Regional Hospital
Sentara Leigh Hospital
Sentara Martha Jefferson Hospital
Sentara Northern Virginia Medical Center
Sentara Obici Hospital
Sentara Princess Anne Hospital
Sentara RMH Medical Center
Sentara Virginia Beach General Hospital
Sentara Williamsburg Regional Medical Center
Sentara Heart Median Time—60 MINUTES
.7 8
2 2 TOTAL CATH LABS
24 SENTARA HEART 25
ElectrophysiologySentara Heart Hospital has one of the country’s leading
electrophysiology (EP) programs, featuring four EP labs with
advanced 3D mapping systems and a separate Hybrid Cardiac
Operating Suite. Our board-certified electrophysiologists
treat heart rhythm disturbances using the latest devices and
advanced procedures that take place inside the heart without
the need for open surgery.
In 2016, Sentara Heart electrophysiologists performed more
than 900 catheter ablations to treat cardiac arrhythmias,
including atrial fibrillation, ventricular tachycardia and
supraventricular tachycardia. This minimally invasive
procedure targets areas of the heart causing the arrhythmia.
We also have a number of clinical research opportunities that
give patients access to the latest cardiac care technologies.
Leadless Device Therapy
As one of the busiest electrophysiology programs in Virginia, the
sophisticated device therapy program at Sentara Heart performs more
than 1,600 device procedures each year.
In 2016, Sentara Heart Hospital became one of the first hospitals in
Virginia to offer the world’s smallest leadless
(wire-free) pacemaker, the Micra®
Transcatheter Pacing System. This device
regulates heart rhythm for patients with
bradycardia, a slow or irregular heartbeat of
fewer than 60 beats per minute.
Traditional pacemakers rely on leads, or wires, to provide
an electrical connection between the device and heart. If these leads
malfunction or an infection develops in surrounding tissue, patients must
undergo another surgery to replace the device and leads.
Micra is about the size of a large vitamin and weighs the same as a
penny. Sentara electrophysiologists use a transcatheter procedure to
implant the wire-free device directly into the heart’s right ventricle
chamber where it delivers electrical stimulation to the heart.
• Automatic pacing: Micra automatically adjusts the heart’s pacing
based on a patient’s activity level.
• MRI compatibility: Traditional pacemakers contain metals that can’t
undergo magnetic resonance imaging (MRI). Micra doesn’t contain
these metals, which means patients can get advanced imaging
diagnostic procedures.
• Permanent placement: Should a patient need more than one heart
device, doctors can turn off Micra and implant a new device—while
Micra stays in the heart—without risk of electrical interaction.
Permanent His Bundle Pacing
Sentara electrophysiologists also are among a select
few in the region with the expertise to perform a
pacemaker technique known as permanent His bundle
pacing (PHBP). The bundle of His is a group of heart
muscle cells that transmits electrical impulses from
the atrioventricular node to the left and right ventricles.
Patients with congestive heart failure and bundle
branch disease traditionally require cardiac
resynchronization therapy (CRT) to treat heart rhythm
problems. CRT involves placing leads, or wires, into
the right and left ventricles to generate simultaneous
pacing of the two ventricles.
With PHBP, our electrophysiologists position the
pacemaker leads to directly engage the bundle of His.
This alternative therapy enables patients to maintain a
regular heart rhythm with less risk of heart muscle
damage than traditional right ventricular pacing.
In July 2016, Sentara Heart Hospital became one of the first hospitals
in the area to implant the world’s smallest pacemaker in patients
with bradycardia. The Micra® Transcatheter Pacing System (TPS) is
a new device that provides patients with the most advanced pacing
technology at one-tenth the size of a traditional pacemaker. Micra is
the only leadless pacemaker approved for use in the U.S. The device
is small enough to be delivered through a catheter and implanted
directly into the heart with small tines, providing a safe alternative to
conventional pacemakers without the complications associated with
leads – all while being cosmetically invisible.
The Micra TPS is also designed to automatically adjust pacing
therapy based on a patient’s activity levels. The Micra TPS is the
first and only transcatheter pacing system to be approved for both
1.5 and 3 Tesla (T) full-body magnetic resonance imaging (MRI)
scans, providing patients with access to the most advanced imaging
diagnostic procedures available, if and when they need one.
Sentara Implants World’s Smallest Pacemaker
27SENTARA HEART26
Charles Southall’s Sentara Heart Care Team at Sentara CarePlex Hospital
PATIENT
Sentara Heart
Emergency staff goes the extra mile—literally
D ale Hoak, a 74-year-old retired
William and Mary history professor,
remembers only a few parts of the
late spring evening that started with him in his
kitchen and ended with emergency surgery.
“I felt some constricting in my throat
muscles,” Dale says. “I went to put water on
my face, and it didn’t help. I had to crawl
about 20 feet to my sofa.”
Dale’s wife called for an ambulance, and the
couple soon arrived at Sentara Williamsburg
Regional Medical Center. Dale believes he
went in and out of consciousness as nurses
monitored him and doctors ordered tests.
“I heard Dr. (Paul) Cash say, ‘It’s what I hoped
it wasn’t,’” Dale recalls. He had experienced
an aortic rupture, with the interior lining of his
aorta coming loose, and needed surgery
immediately to repair it.
Sentara Nightingale Regional Air Ambulance
often transports patients such as Dale to
Dale Hoak
another facility under these circumstances.
However, on that June evening, fog grounded
Nightingale. Dr. Cash and Janet McCoig, an
emergency department nurse whose shift was
ending, arranged for an ambulance to
transport Dale to Sentara Heart Hospital,
about an hour away in Norfolk.
“They actually got in the ambulance with me,”
says Dale. “That’s not what usually happens.
They kept me alive. They wanted to watch my
blood pressure and try to keep it as low as
possible.”
A few hours later, Dr. John Sirak at Sentara
Heart Hospital repaired Dale’s aortic tear and
inserted a valve to keep the aorta functioning.
“I learned that what happened to me is
caused by an aortic aneurysm. Dr. Philpott,
who helped me after the surgery, said that on
a scale of one to 10, with 10 being lethal,
I was a 9.5,” Dale shares. “They didn’t know
if I would survive; after nine hours of surgery,
I woke up OK.”
Dale stayed in the hospital for 15 days and
then headed home, with a promise to monitor
his health. The aorta aneurysm he had faced
is a condition that can be detected with
screenings conducted at Sentara Aortic Center
and then treated.
Dale also attended cardiac rehabilitation at
Sentara Williamsburg Regional Medical
Center. About a month later, Dale saw
Dr. Cash and Janet in the lobby of Sentara
Williamsburg, where he was attending his
rehab classes every Monday, Wednesday and
Friday for 10 weeks.
“Dr. Cash told me he’s never seen anyone so
dire as me,” Dale says. “I thanked them both
profusely and asked that they give my thanks
to several other Sentara Williamsburg nurses
who helped me.”
“They actually
got in the
ambulance with
me,” says Dale.
“That’s not what
usually happens.”
29SENTARA HEART28
SENTARA HEART HOSPITAL SENTARA RMH MEDICAL CENTERSENTARA VIRGINIA BEACH GENERAL HOSPITAL
2014-16 Primary Coronary Artery Bypass Graft
(CABG) In-Hospital O/E Mortality RatioSource: Sentara Heart
Source: Sentara Heart
Atrial Fibrillation Reduction
in the Post-Surgical CABG Patient
Presence of Afib is known to contribute to an extended length
of stay and stroke complications for the hospitalized patient. A
clinical workgroup sought to address this issue by developing and
standardizing a process to implement Afib prophylaxis utilizing an
antiarrhythmic medication, Amiodarone, for all CABG patients,
perioperatively. The implementation of this clinical initiative
resulted in a decreased hospital stay by 3.8 days and an overall
decrease in Afib occurrence.
A ratio of less than 1.0 means that fewer patients died
than expected based on the performance of other
hospitals as adjusted for patients with the same types
and severity of medical problems.
.92
0.52
What does the O/E mortality ratio mean?The observed-to-expected mortality outcome (O/E mortality
ratio) is a risk-adjusted measure of a hospital’s mortality (death)
rate. Risk adjustment takes into account how sick patients are
upon entering the hospital. The mortality observed-to-expected
measure tells us how we are performing on mortality relative to
what is expected for our patients, given a variety of complicating
characteristics, including their age, chronic conditions like
diabetes or heart failure, or whether the patient was transferred
from another hospital or admitted as an emergency. An O/E ratio
less than 1.0 indicates better than expected outcomes and an O/E
ratio greater than 1.0 indicates poorer than expected outcomes.
(For example, an O/E ratio of 0.50 for mortality would mean
that mortality was only 50% of the expected value; conversely a
mortality ratio of 1.50 means that mortality was 150% of expected
or 50% higher than expected.)
• Coronary Artery Bypass
• Ablation Procedures
• Aortic Root Replacement
• Aortic Valve Replacement
• Heart Transplant
• Minimally Invasive Mitral Valve Surgery
• Mitral Valve Repair/Replacement
• Open Pericardiectomy
• Open Repair Aortic Aneurysm/Dissection (Ascending & Descending)
• Minimally invasive lung or mediastinal mass resection for diagnostic and therapeutic purposes
• Metastatectomy for advanced cancers
Procedures performed at Sentara Heart include:
Most common thoracic procedures include:
23.2
29.6
20.62
22.9
6.06
16.6
11.5
13.8
18.4 18.9
12.5
14.6
Occurrence of Atrial Fibrillation
Post-Cardiac Surgery
• Resection of Cardiac Tumor
• Repair Atrial Septal Defect
• Repair Patent Foramen Ovale
• Repair Ventricular Septal Defect
• Repair Ventricular Aneurysm
• Transmyocardial Revascularization
• Tricuspid Valve Repair/Replacement
• Ventricular Assist Device Placement
• Endovascular Repair of Thoracic Aneurysm (TEVAR)
• Decortication, manual and chemical pleurodesis and lung volume reduction surgery
Cardiothoracic SurgeryCardiothoracic surgery at Sentara Heart is a highly regarded
program with nationally recognized surgeons, superior quality
and complex cases. Much like that of an academic center, this is
a deep and diverse program that continues to treat increasingly
acute cases. It is also a program that can serve the many
needs of patients in one place, sometimes in a single visit with
multidisciplinary approaches offered in many programs for
structural heart, thoracic oncology and aortic patients.
In 2016, the cardiothoracic surgery program reached an important
milestone with 50,000 open heart cases being performed by the
MACTS surgeons and Sentara Heart surgery team. Last year
alone, the surgeons from Mid-Atlantic Cardiothoracic Surgeons
(MACTS) and Sentara RMH Cardiothoracic Surgery managed
more than 2,200 cases at Sentara Heart Hospital, Sentara Virginia
Beach General Hospital and Sentara RMH Medical Center. The
cardiothoracic program brought innovative procedures new to
Sentara Heart such as open Cox-Maze IV, WATCHMAN device for
atrial fibrillation, intuity aortic valve and mitra-clip.
Mid-Atlantic Cardiothoracic Surgeons work closely with pulmonary
medicine, oncology and radiology to provide a multidisciplinary
approach to thoracic surgery. Our surgeons lead the regional effort
to launch lung cancer screenings, participate in national Society
of Thoracic Surgeons (STS) quality metrics, and perform sleeve
thoracic surgeries (a highly complex procedure involving the lung).
This surgical group is highly regarded for its efforts to advance
cardiovascular and thoracic practices. Individually, its members
serve on a multitude of national committees.
31SENTARA HEART30
Cardiac AnesthesiologyWith 10 board-certified cardiothoracic anesthesiologists, Sentara
Heart provides 100 percent physician-staffed anesthesiology services.
The physicians of Anesthesia Specialists work exclusively with the
cardiothoracic surgeons and cardiologists, allowing patients to
benefit from a dedicated and collaborative team of physician experts
who perform high volumes of innovative procedures. Each one has
completed a full residency in general anesthesia as well as advanced
fellowship training in cardiothoracic anesthesiology and critical care.
Cardiothoracic anesthesiologists are exclusively dedicated to the care of patients undergoing surgery of the heart and lungs. They assist in the following cases:
• Coronary artery bypass surgeries
• Valve repairs and replacements
• Open aortic procedures
• Thoracic and lung surgery
• Heart transplant
• Ventricular assist devices
• High-risk interventions in the
cath lab
• Transcatheter aortic valve
replacement (TAVR)
• MitraClip
• WATCHMAN left atrial appendage
closure device
• EP Lab procedures, ablations,
pacemakers, and implantable
cardioverter defibrillators (ICD)
• Extracorporeal life support (ECLS),
including extracorporeal membrane
oxygenation (ECMO)
Cardiothoracic anesthesiologists at Sentara Heart immerse themselves in advanced
training and technologies. They collaborate on innovative procedures such as
MitraClip, WATCHMAN, and TAVR. Many of the cardiothoracic anesthesiologists are
actively involved in hospital leadership committees focusing on patient safety, clinical
quality, root cause analysis, best practices, ethics, and more.
The dedicated, skilled and experienced cardiothoracic anesthesiology team
contributes to the ability of Sentara Heart to provide services that would otherwise
not be available in the community. They play a crucial role in producing excellent
morbidity and mortality rates, especially given the acuity level of the population
we serve.
This team of subspecialists excels in the management of critically ill
patients undergoing complex operations, which encompasses the use
of invasive monitoring techniques, single-lung ventilation, management
of cardiopulmonary bypass, advanced hemodynamic management,
and the control of postoperative pain. They are skilled at reading and
interpreting intraoperative transesophageal echocardiograms. This
allows the team to diagnose unexpected coronary and valve problems,
confirm already suspected disease processes, and determine the
success of a procedure, all within the surgical suite.
32 SENTARA HEART 3332
In 2016, Sentara Heart and Sentara Vascular
Specialists initiated efforts to more closely
align our nationally recognized cardiac and
vascular programs. It’s estimated that two-
thirds of Americans with vascular disorders
also have heart problems.
Sentara Vascular Specialists is comprised
of 17 vascular surgeons and two transplant
surgeons. This group of experts performs
more than 9,000 vascular procedures every
year and has deep expertise in treating
patients with simple to extremely complex
circulatory disorders.
Vascular Interventional Center
The Vascular Interventional Center at Sentara
Norfolk General Hospital (SNGH) is one of the
country’s most technologically advanced and
comprehensive centers of its kind. The center
features a dedicated preoperative area and
intensive care unit specifically for patients
undergoing vascular procedures.
Sentara Vascular Specialists work closely with
cardiology, radiology and oncology experts
to provide a multidisciplinary approach to
vascular and endovascular surgery. The
center’s hybrid operating room has top-of-the-
line imaging technology found only at a select
few hospitals nationwide. Here, our vascular
surgeons use advanced endovascular
techniques to perform complex procedures,
such as abdominal and thoracic aortic
aneurysm repair. We began work on a second
hybrid operating room in 2016, to be open in
the fall of 2017.
Vascular Services
Endovascular suites at each Sentara hospital
allow our physicians to use the newest
technology to treat a range of vein and artery
disorders, including deep vein thrombosis
(DVT), blockages, tears, aneurysms and
abnormal narrowing of arteries. Sentara
Vascular Specialists treat all disorders
involving the circulatory system, peripheral
arteries and veins. Vascular services include:
• Balloon angioplasty and stenting
• Treatment of peripheral artery disease
(PAD), carotid artery disease, kidney
disease, diabetic vascular disease and
venous disease
• Vein access for dialysis and chemotherapy
• Limb amputation prevention and
rehabilitation
Vascular
ProgramSentara Norfolk General Hospital
35SENTARA HEART34
Amputation
Aortic Surgery
Carotid Surgery
41 7
47 5
3 0 0Dialysis Access
Peripheral Vascular
Vein Procedures
Non-invasive Vascular
1,3 9 7
5,7 9 2
9 6 7
6 7,6 3 8
2016 VolumesVascular Program
VASCULAR PROGRAM
Vascular Center Achievements
Our vascular specialists are internationally recognized for superior
quality and innovation in treating increasingly complex cases. The
team’s achievements include:
• One of the first participants in the Vascular Quality Initiative. This
Society of Vascular Surgery program allows us to benchmark and
compare outcomes against other vascular centers nationwide.
• Nationally respected vascular surgery fellowship. Our vascular
surgery fellowship program, run through Eastern Virginia Medical
School (EVMS), is one of the largest in the country. We accept three
new fellows every year for a two-year program.
• Global leaders in vascular research. Our vascular team ranks
among the top 5 percent in enrollment for clinical trials in which
we participate. At any given time, at least 20 clinical trials are
underway at Sentara. The breadth of our research is vast, focusing
on potentially life-saving advancements such as lower extremity
revascularization, innovative stent and balloon technology, and
carotid, aortic and venous interventions.
• Stewards of best practices. Our vascular experts share expertise
and best practices with other medical professionals every year at
the Current Concepts in Vascular Therapies Mid-Atlantic Conference
hosted by Sentara and EVMS.
• Transplant experts. Sentara Vascular Specialists is the only group in
Hampton Roads and eastern North Carolina that performs kidney
and pancreas transplantations.
• Vein specialists. Our vascular experts treat varicose veins, spider
veins and other vein diseases at four Vein Center of Virginia
locations statewide.
Advanced Aortic Program
The aortic experts at Sentara Vascular
Specialists are internationally recognized for
their skill at treating the most complicated
aortic disease problems. Our surgeons
provide a complete range of diagnostic and
treatment services for abdominal aortic
aneurysms, thoracic aortic aneurysms, aortic
dissection and other types of aortic disease.
Since 2009, the Advanced Aortic Program has
seen a 40 percent increase in patient cases.
This growth is largely attributed to our
experts’ ability to use the most innovative
procedures and devices in order to manage a
range of conditions from simple to complex.
Some of the advanced procedures available at
Sentara include:
Thoracic Endovascular Aortic Repair (TEVAR):
Sentara has one of the country’s largest
thoracic aortic programs. When possible, we
use a minimally invasive procedure called
thoracic endovascular aortic repair (TEVAR) to
repair the aorta, the body’s major blood
vessel. Thanks to our success at performing
hundreds of TEVAR procedures, Sentara
is among a select handful of centers
nationwide asked to participate in two
landmark device studies. Our involvement in
aortic clinical trials has increased nearly 90
percent since 2000, a true reflection of our
program’s excellence.
Central Venous Program According to the American Heart
Association, venous thromboembolisms
(VTE), blood clots that originate in a vein,
are the third leading cause of cardiovascular
death after heart attack and stroke. VTEs
affect between 600,000 and 1 million
Americans every year. Types of VTEs
include deep vein thrombosis (DVT), a
blood clot in a deep vein in the leg or arm,
and pulmonary embolism (PE), a blood clot
that breaks free from a vein and travels to
the lungs.
Sentara Vascular Specialists are national
leaders in the use of an innovative surgical
technology called the AngioVac Cannula
and Circuit System to remove difficult-to-
access clots. Previously, removal of certain
clots in the heart or abdomen required
open surgery, which often resulted in
significant blood loss. With the AngioVac
System, our surgeons often perform the
procedure percutaneously through the skin.
The circuit part of the AngioVac System
creates an extracorporeal bypass that
filters blood outside of the body during the
removal of the clot, which is done by
suctioning with the AngioVac cannula.
During surgery, a reinfusion cannula sends
filtered blood back into the body, minimizing
blood loss.
Using this technology, Sentara vascular
surgeons have successfully removed clots
from the heart’s right atrium, inferior vena
cava and superior vena cava. In 2016,
Sentara surgeons were among the first in the
country to use AngioVac to remove a blood
clot in a pediatric patient’s right atrium.
As a high-volume center for AngioVac
procedures, Sentara surgeons perform
about two procedures per month and are
sought after to share their expertise at
conferences worldwide.
In Situ Fenestration: We are a world leader in
an innovative TEVAR procedure called in situ
fenestration to revascularize aortic branches
during aortic emergencies. During urgent
situations, our vascular surgeons use lasers
to make holes (fenestrations) in stent grafts to
accommodate brachiocephalic or visceral
arteries. The stent grafts are used to
reconstruct the aorta and its major branches.
Fenestrated Endovascular Aortic Repair
(FEVAR): Our doctors are among the most
experienced in the region at performing FEVAR
procedures to treat complex abdominal aortic
aneurysms once considered inoperable. Our
vascular surgeons use computed tomography
(CT) imaging scans to custom design a graft
that has pre-made holes, or fenestrations. The
fenestrated graft is positioned using fusion
imaging technology to reconstruct the aorta
and the arteries that branch off from the aorta
to the kidneys, liver and small bowel.
Thoracic EndoAnchors®: Sentara vascular
surgeons were the first in the country to use
thoracic endograft anchoring technology, or
EndoAnchors, to stop blood leaks (endoleaks)
which can occur following a thoracic
endovascular aortic repair. These devices
strengthen the seal between a stent graft and
the aorta, effectively stopping leaks. We
perform more of these procedures at Sentara
than any other medical center in the world.
36 SENTARA HEART 37
Sentara Heart Arrhythmia Center Offers:
• A hybrid team approach toward patient care—both a
cardiothoracic surgeon and cardiac electrophysiologist review
every option with patients to determine the best treatment plan
• Comprehensive Afib treatment program that includes an advanced
heart mapping system, advanced diagnostic testing and leading-
edge procedures not available anywhere else in the region
• The only advanced hybrid EP cardiovascular operating room in
Southeastern Virginia
• Services tailored to referring doctors, ranging from one-
time recommendations for medical management to invasive
interventions
The Sentara Heart Arrhythmia Center (SHAC) is one of the few centers
in the country with the expertise and technology to perform all of the
most revolutionary ablation procedures available for the treatment of
heart arrhythmias.
The center is also a national leader in performing the Open Cox
Maze IV and minimally invasive Cox Maze procedures, as well as
hybrid surgical ablation.
Doctors at the SHAC are committed to employing the latest methods
and tools to treat Afib, which is a growing national health concern.
Sentara Heart is experiencing an increase in the number of patients
seeking treatment for Afib. The risk of developing this heart rhythm
disorder, which affects nearly 5.1 million Americans, increases with
age. As the Baby Boomer generation gets older, the number of people
with Afib could triple to 15.9 million by 2050.
Individuals seeking arrhythmia care comprise a very diverse group,
some of whom require complex therapies. The SHAC provides a
resource for managing unique patients across the region with seamless
access to advanced diagnosis and medical and interventional
treatments—all within one setting. We are the only center in
Southeastern Virginia to bring together highly talented cardiothoracic
surgeons and cardiac electrophysiologists in a highly collaborative
approach to cardiac care. We consider this centralized treatment process
to be an important step forward for patient care and satisfaction.
cardiologists at Sentara Heart Hospital to
develop an arrhythmia program that
allowed expansion of an arrhythmia clinic
and service offerings throughout the
Hampton Roads region. This will allow
the SHAC to better meet the growing demand
for arrhythmia care and electrophysiology
procedures.
Cardiac lead removal continues
to be an area of growth for the
SHAC. There is a growing need
for doctors at the SHAC to
perform cardiac lead removal
procedures as part of the
normal course of management
of implantable devices such as
cardiac resynchronization therapy
defibrillators (CRT-Ds), implantable
cardioverter defibrillators (ICDs), and
pacemakers.
To contact the Sentara Heart Arrhythmia
Center, call (757) 388-8020 or go online to
sentara.com/Afib.
• A dedicated program navigator who
provides a single point of contact to
referring doctors and patients through
the entire care cycle process
• Access to advanced Afib research studies
that are among the top enrollers in the
nation, including:
o ARCA Biopharma Genetic-AF trial
o AtriCure Hybrid DEEP Pivotal AF trial
o AtriCure ABLATE study for open maze
procedures
Areas of Growth
The SHAC is continuing its development of
integrated services and use of the Hybrid
Cardiac Operating Suite. Cardiothoracic
surgeons, cardiac electrophysiologists and
cardiothoracic anesthesiologists work closely
together to handle complex treatments and
surgeries for patients requiring more in-depth
procedures. The increasing efficacy and
success of these complex procedures is a
testament to the benefits of a highly
collaborative and hybrid approach to care.
The SHAC also dramatically increased its
community outreach efforts and coverage for
patients who require arrhythmia management,
providing ablation procedures and standard of
care therapy for flutter and fibrillation to
under-served and under-resourced areas of the
Hampton Roads community. In 2015, the
SHAC worked with Sentara Heart
Sentara Heart
Arrhythmia CenterProgram Leads
Jonathan Philpott, MD, Cardiothoracic Surgeon
Philip Gentlesk, MD, Cardiac Electrophysiologist
39SENTARA HEART38
Sentara Advanced
Heart Failure Center
Medical Director, John Herre, MD,
Advanced Heart Failure Cardiologist
Surgical Director, Christopher Barreiro, MD,
Cardiothoracic Surgeon
The number of people being diagnosed with heart failure
continues to increase with nearly 6 million Americans
currently affected. To serve the needs of this burgeoning
population, Sentara Heart expanded the Sentara Advanced
Heart Failure Center in 2014—doubling its capacity.
The center has four subspecialized programs, each with
their own distinct specialists and clinics.
Normal Body Function
Heart Failure
CardioMEMs™
On October 30, 2015, center physicians implanted CardioMEMS™, a new,
miniaturized, wireless heart failure monitor, into the pulmonary arteries
of eight patients. Sentara Heart was the first in Southeastern Virginia to
perform this procedure.
The CardioMEMS™ system has no wires or batteries, allowing for
greater ease of mobility. Daily pulmonary pressure readings taken at
a patient’s home and transmitted to the center enable specialists to
detect warning signs of heart failure up to 45 days before the onset
of symptoms. Clinicians can immediately alter a patient’s treatment
to prevent problems from worsening. This proactive step decreases
the chances of hospitalization, improves quality of life and reduces
healthcare costs.
In clinical trials, CardioMEMS™ reduced hospital
admissions by 37 percent.
Ventricular Assist Devices (VADs)
Sentara Heart is among select U.S. hospitals chosen by
manufacturer Thoratec to participate in a clinical trial to evaluate
the effectiveness and safety of a new ventricular assist device, or
VAD, called HeartMate III. The center’s surgical director, Michael
McGrath, MD, is leading the Momentum 3 trial at Sentara Heart.
The HeartMate III incorporates advanced technology that makes surgical placement easier.
Single-sided cables enable patients to discreetly slip the external portions of the device into
a front pocket and enjoy a more active lifestyle. In 2015, Sentara Heart surgeons implanted
the HeartMate III into three patients.
LVADs help the heart’s left ventricle (the main pumping chamber of the heart) deliver blood
to the rest of the body. Long-term VADs may serve as bridges to transplantation, stabilizing
heart failure patients until a heart transplant is possible, or as destination therapy for those
with more advanced heart failure who are not transplant candidates.
1,100 patient treatments
More than 1,100 patients receive treatments—ranging
from medication management to the latest innovative
technologies—through this cutting-edge program.
“Newer indications and devices allow us to care for the full
spectrum of patients with heart failure”
— John Herre, MD, Medical Director, Advanced Heart Failure Center
Sentara Heart Hospital LVAD program’s patient survival (red line)
far exceeds that of the national patient survival experience (blue line).
In 2016, Sentara Heart
provided:
12
35
Heart Transplants
Long-Term VADs
30 Short-Term VADs
A ventricular assist device (VAD) is a mechanical pump that is used to support heart function and blood flow in people who have weakened hearts. It is used to stabilize a patient for up to a few days (short-term VAD) or as a bridge to heart transplant to a long-term solution (long-term VAD) to help a heart work better.
40 41SENTARA HEART
Milton Hugate
M ilton Hugate has always been an
active person. At age 83, he still
likes to mow his yard and his
neighbor’s. Living in a rural area of Virginia with
large lawns, the mowing is no easy task. Yet, he
has always taken on the challenge with no
problems – except when he started to have
trouble breathing.
“For about eight months starting in late 2015,
Milton struggled even walking from the living
room to the bathroom,” shares his wife,
Margaret. “He couldn’t do it without losing
his breath.”
But Milton wouldn’t stop his usual activities.
In May 2016, he spent a day working with a
chain saw and walking up and down stairs.
When he came inside and finally sat in the
kitchen, he collapsed into his daughter’s arm.
He was rushed to a non-Sentara Healthcare
PATIENT
Sentara Heart
A fast recovery after a quick fix
hospital, diagnosed with severe aortic
stenosis (a narrowing of the heart’s aortic
valve opening), and asked to undergo a valve
replacement at another non-Sentara facility.
Milton’s daughter, Donna, had another idea.
As a nurse practitioner, she wanted to
investigate all of the treatment possibilities.
A call to a friend led her to the Sentara
structural heart team and evaluations for her
father at Sentara Heart Hospital.
“The staff worked it so we could have a lot of
the pre-testing done at one time, so we didn’t
need to do much driving back and forth. The
testing and the operation were scheduled
quickly, and it all went fast. Milton had his
procedure on a Wednesday and left the
hospital that Friday,” Margaret said. “He had
great care.”
Milton had a TAVR, a transcatheter aortic valve
replacement, a minimally invasive procedure
that can sometimes be used as an alternative
to open heart surgery. It is also known as TAVI,
a transcatheter aortic valve implantation.
Sentara Heart Hospital is one of a select group
of heart centers across the country that
pioneered the method.
TAVR allows doctors to replace a damaged
valve without removing it. Working with a
catheter, they deliver a collapsible
replacement valve to the site. When they
expand the new valve, the old valve leaflets
are pushed out of the way.
Within a few days of returning home, Milton
met with an in-home physical therapist. She
set up a walker for him and said they would
go at his pace. Little did she know that the
pace would be fast: When she turned around
to check on something, Milton was up and
walking down the hall.
“He felt great almost right away,” says
Margaret. “He’s doing anything he wants—
working in his shop and cutting the grass.
Anything that needs fixing, he tries to take
care of it.”
42 43SENTARA HEART
Medical Director, Michael Eggert, MD, Pulmonologist
Advanced Practice Clinician, Vanessa Knowles, MSN, RN, FNP-C
Pulmonary Arterial Hypertension (PAH)
For more than a decade, Sentara Heart has been a pioneer in the
specialized diagnosis and treatment of a rare, often-fatal heart and lung
disease called pulmonary arterial hypertension, or PAH. PAH is a type of
high blood pressure in the lungs that causes the arteries in the lungs to
tighten and stiffen. This forces the right side of the heart to work harder
to push blood out of the heart, through the lungs and into the rest of
the body. Over time, this extra stress causes the right side of the heart
to enlarge and eventually to fail.
Michael Eggert, MD, medical director of the PAH program at the
Advanced Heart Failure Center, refers to PAH-induced right-sided heart
failure as “the other heart failure.” The disease often goes undiagnosed
or is misdiagnosed until it has progressed to a more advanced stage.
“In the 1990s, before specific therapies were developed, half of PAH
patients died within three years of diagnosis,” says Dr. Eggert. “Today,
our survival time from diagnosis has more than doubled, with some
patients living more than 15 years, when the disease is caught and
treated early. In time, we may be able to add even more time to
patients’ lives with better disease detection and management and the
possibility of transplantation.”
In 2016, Sentara Heart’s Pulmonary Hypertension Clinic was accredited
as a Pulmonary Hypertension Association Regional Clinical Program
(RCP). This designation of clinical excellence recognizes Sentara Heart’s
status as a leader in PAH diagnosis and treatment and will further
increase the program’s visibility while enhancing regional clinical
research and collaboration.
Sentara Heart PAH program highlights include:
• Disease management of more than 300 patients, which is
comparable to patient populations seen at large state academic
medical centers
• Annual diagnostic evaluation of several hundred patients
Normal Pulmonary Artery
Pulmonary Artery with Hypertension
• Multidisciplinary PAH care team comprised of a transplant-trained
pulmonary hypertension cardiologist, pulmonologists, cardiologists,
cardiopulmonary rehab specialists, nurses, cardiac respiratory
therapists, clinical coordinators and research coordinators
• Specifically designated inpatient units within Sentara Heart for
disease management of PAH patients
• Specialized training of staff at Sentara hospitals, as well as within
the cardiac ICU and advanced heart failure units at Sentara Heart,
in the identification and treatment of PAH
• Participation in national and international clinical trials focused on
identifying new PAH therapies
• Quarterly educational support group meetings in the Hampton
Roads region for patients with PAH and their loved ones
• Annual PAH symposium to raise disease awareness among
clinicians in the medical specialties of pulmonary medicine, critical
care, infectious disease, internal medicine, family medicine and
respiratory care and to discuss the future direction of the diagnosis,
treatment and management of the disease
To contact the Sentara Advanced Heart Failure Center, call (757) 388-2831 or go online to sentara.com/HeartFailure.
The Sentara Norfolk General Hospital Pulmonary Hypertension
Clinic was one of only three centers nationwide to earn
Regional Clinical Program (RCP) designation by the Pulmonary
Hypertension Association (PHA). This accreditation is based on
the program’s ability to deliver quality care to patients living
with a complex, often misdiagnosed, life-threatening disease.
It is the result of participation in a pilot program with the PHA
and a rigorous review process. Conclusion of the RCP pilot has
laid solid groundwork toward meeting the PHCC program goals
of providing increased access for PH patients to high-quality
care and fostering collaboration between regional treatment
sites and those receiving PHA’s Center of Comprehensive Care
(CCC) accreditation.
300
250
200
150
100
50
0
Q42014
Q42015
Q12016
Q22016
Q32016
Q42016
Pulmonary Hypertension Clinic
Episode Count
SENTARA ADVANCED HEART FAILURE CENTER
45SENTARA HEART44
Medical Director, Paul Mahoney, MD, Cardiologist
The Sentara Heart Valve and Structural Disease Center is the only
program in Southeastern Virginia and Northeastern North Carolina
focused on diagnosing and treating heart valve and structural
heart disease.
The center offers the most innovative heart valve repair options
available including the newest generation of valves that doctors
implant through minimally invasive catheterization. The center
was the first in the region to offer these advanced transcatheter
cardiac treatments:
• MitraClip device for mitral valve repair
• Transcatheter aortic valve replacement (TAVR) for severe
aortic stenosis
• WATCHMAN left atrial appendage closure device for
atrial fibrillation
• Parachute investigational device for ischemic cardiomyopathy
In addition, the center continues to perform a high volume of other types
of heart valve repair and replacement surgeries including percutaneous
aortic and mitral balloon valvuloplasty, atrial septal and ventricular
septal defect repairs, closures of paravalvular leaks, and as a result of
the multidisciplinary approach, traditional aortic valve surgeries.
Program Team
Neville Mistry, MD, Cardiologist
Lauren Morris, PA-C, Advanced
Practice Clinician
Marianna Garcia , PA-C,
Advanced Practice Clinician
Kelley Meredith, PA-C,
Advanced Practice Clinician
Elizabeth Willette, NP
Sentara Heart Valve and Structural Disease Center
6 9 6Dec 2011 2012 2013 2014 2015 Dec 2016
TAVRHeart Team
ReviewFollow-Up
Visits
Total TAVR Procedures Performed from
December 2011 - December 2016
At the center, a program navigator guides first-time patients through
the referral and screening process. Upon completion, a team of
interventional cardiologists, cardiothoracic surgeons and advanced
practice clinicians work collaboratively to assess the patient’s condition
and determine the most appropriate course of therapy or treatment.
The result is an individualized disease management plan tailored
specifically to a patient’s cardiac needs.
The program navigator and coordinators provide a single point of
contact for referring physicians, providing updates on a patient’s
progress and communicating follow-up care management upon the
patient’s discharge from the center.
Rapidly growing advancements in minimally invasive heart surgery
are yielding faster recoveries and improving patient satisfaction and
comfort – all with less visible scarring. Because of these benefits,
doctors at the center perform catheter-based heart procedures for most
single-valve repairs and replacements whenever possible.
4746 SENTARA HEART
Sentara Heart Valve and Structural Disease Center
WATCHMAN
For the past decade, Sentara Heart has been an active participant
in clinical trials for the WATCHMAN left atrial appendage (LAA)
closure device. Doctors at Sentara Heart have implanted over 100 of
the devices since FDA approved the WATCHMAN in March of 2015.
The WATCHMAN is a self-expanding device that seals off the LAA,
a small pouch off the left
side of the heart where
blood clots can form in
patients who have
atrial fibrillation (Afib).
At first, a mesh
membrane on the
device acts as a filter,
allowing blood to flow
through while stopping
clots from entering the
bloodstream where
they can cause strokes.
Eventually, heart tissue grows over the device, permanently sealing
off the LAA.
LAA occlusion eliminates the risk of stroke without the need for
blood thinners, which is great news for the many patients who are
unable to take them due to side effects or bleeding risks. Most
patients who receive the WATCHMAN go home within 24 hours and
can stop taking blood thinners within two months.
Transcatheter Aortic Valve Replacement (TAVR)
Sentara Heart is proud to be one of a select group of distinguished
heart centers across the country that helped pioneer transcatheter
aortic valve replacement (TAVR), a minimally invasive treatment to
replace diseased aortic valves. Since the program began in December
of 2011, the center has completed 696 TAVR procedures—nearly 243 of
them in 2016 alone.
TAVR is a highly innovative treatment for patients who suffer from
severe aortic stenosis, a condition caused by a narrowing of the aortic
valve due to calcium buildup. This restricted opening reduces blood
flow leading to extreme fatigue, severe shortness of breath, and
possible heart failure. Many patients who have severe aortic stenosis
also have other health issues, like diabetes or lung disease, that make
them high-risk candidates for open-heart valve replacement surgery.
SENTARA HEART VALVE AND STRUCTURAL DISEASE CENTER
The Center’s Latest Advancements Include:
MitraClip
In June 2014, Sentara Heart was the first in the region to offer a first-of-
its-kind device called the MitraClip to treat heart failure patients who
have mitral regurgitation. Mitral regurgitation is the most common
heart valve problem in the U.S., affecting approximately 4 million
people. An estimated 50,000 Americans undergo mitral valve
repair surgery every year. Because MitraClip is a minimally
invasive catheter-based implant procedure, it is a welcome
option for heart failure patients whose conditions are so
severe that they cannot undergo open chest surgery.
MitraClip attaches to the mitral valve leaflets creating
a double opening of the mitral valve. This allows for
greater closure and reduces the leakiness of the valve.
Sentara Heart doctors have performed 92 MitraClip
procedures. Studies show that patients who receive MitraClip
have fewer hospitalizations and enjoy an improved quality of life.
Sentara Heart also is participating in the Cardiovascular Outcomes
Assessment of the MitraClip Percutaneous Therapy (COAPT) clinical
trial, a national study comparing the effectiveness of MitraClip to
medical therapy for heart failure patients who are not candidates for
traditional mitral valve surgery. Cardiologist Paul Mahoney, MD, is the
study’s principal investigator.
To contact the Sentara Heart Valve and Structural Disease
Center, call (757) 388-6144 or go online to sentara.com/
HeartValveCenter.
2014
144
2015
193
2016
243
Because TAVR is a catheter-based procedure, it can be a good
alternative for high-risk and elderly patients once considered
inoperable.
With this minimally invasive procedure, doctors at Sentara Heart
can repair the aortic valve without removing the old, damaged
one. Instead, they use a catheter to place a balloon-expandable
replacement valve into the heart. Most patients are often out of the
ICU in a day and home within 72 hours.
Sentara Heart is participating in the PARTNER-II and SURTAVI
clinical trials studying TAVR. Dr. Mahoney and cardiothoracic
surgeon Joseph Newton, MD, are leading both studies.
TAVR Program Growth(Does not include clinical trial volume)
4948 SENTARA HEART
The team provides fast, accurate diagnoses and treatments in our Advanced Imaging Center
and Hybrid Cardiac Operating Suites. Treatment options for aortic conditions at Sentara include
medication management, minimally invasive endovascular surgery, ascending aorta and aortic
arch open surgery, and valve-sparing surgery.
The Sentara Aortic Center serves as a medical home for patients needing long-term disease
management, providing medical management of hypertension, genetic counseling, patient and
family education, and ongoing monitoring via diagnostic and imaging tests.
Aortic Alert Program
The Sentara aortic emergency call system is helping to save lives. If an aortic emergency occurs
at a Sentara hospital, staff need only dial 1-2 within the hospital
to put the Aortic Alert Program into immediate effect.
This system connects the caller with a highly trained operator who assesses the situation and
deploys the aortic disease team. Together, they use their expertise to create a personalized plan
for a patient’s aortic care.
Since the Aortic Alert Program went into effect in 2014, Sentara hospitals have
seen dramatic improvements in the following areas:
Outside Sentara, someone experiencing an aortic emergency can call
(844) 601-2255 or (757) 252-9001.
Sentara Aortic Center
1 hourtime reduction between emergency room arrival and imaging scans 1.5 day
decrease in hospital stays
2 6 min.faster transportation times with the Nightingale Regional Air Ambulance as the primary mode of transportation
Sentara Aortic
Center TeamOur multidisciplinary team of
specialists include:
• Cardiothoracic Surgeons
• Vascular Surgeons
• Cardiologists
• Emergency Department Physicians
• Radiologist/Imaging Specialists
• Geneticist
• Advanced Practice Clinicians
(Nurse Practitioners and
Physician Assistants)
Co-Directors
Jean Panneton, MD, Vascular Surgeon
Jonathan Philpott, MD, Cardiothoracic
Surgeon
Lauren Gillis, MSN, RN, ANP-BC,
Advanced Practice Clinician
The Sentara Aortic Center opened in 2015 and
is one of only a handful of programs in the
U.S. with physicians who specialize in aortic
diseases. The center merges its expertise
with sophisticated technology to ensure fast
and effective diagnoses and treatment of
aortic conditions. The center’s high quality
emergency care and long-term management
of aortic disease is unmatched in the mid-
Atlantic region.
Our multidisciplinary team of specialists
includes experts in aortic disease, emergency
medicine, surgery and imaging—all
working together to deliver exceptional and
compassionate care. The team manages a full
range of aortic conditions including:
• Thoracic aortic aneurysms
• Abdominal aortic aneurysms
• Thoraco-abdominal aneurysms
• Aortic dissection
• Traumatic aortic injury
• Penetrating aortic ulcers
• Intramural hematoma
• Aortic occlusive disease
51SENTARA HEART50
Cardiac NursingHeart patients at all Sentara hospitals receive exceptional care from
our team of highly specialized cardiac nurses. Many of our nurses hold
advanced certifications or degrees, including doctoral degrees,
in various subspecialties. At Sentara, we encourage our nurses to
perform at the highest level of their clinical expertise while providing
support to patients who are undergoing or recovering from advanced
cardiac procedures.
Patients and their loved ones agree that the care provided by Sentara
nurses is extraordinary. Our customer service scores show that patients
consistently rate their overall care at Sentara at the highest level
possible, a 9 or 10 on a scale of 10 (best hospital) to 0 (worst hospital).
Advanced Care for Patients with Chronic Illness
The role of cardiac nurses continues to expand and become more vital
as the care delivery model for each patient increases in complexity.
Many patients have multiple comorbidities or chronic illnesses, such
as heart disease and diabetes. This combination of health problems
can complicate cardiac treatment and recovery. Nurses must manage
the primary reason for hospitalization, such as heart surgery, while
also monitoring other conditions that can interfere with recovery. For
instance, heart patients who also have diabetes often need special
wound treatment to ensure proper healing. Our nurses tap into their
high-level education and training to ensure a patient’s recovery goes as
smoothly as possible with few risks or complications.
Advanced Practice Clinicians Perform Top-of-License Work:
• Coordination of care through ambulatory clinic and physician
practice sites
• Assistance with advanced structural heart procedures
• Cardiothoracic surgery program support
• Assistance with complex catheter ablations in electrophysiology
and catheterization labs
• Management of advanced heart failure patients
• Support for a range of bedside procedures
Nurse-Directed Stress Testing
Over the past decade, the responsibility for performing heart stress
tests has shifted from physicians to cardiac nurses. Under the guidance
of a cardiologist, Sentara cardiac nurses who have completed special
training conduct exercise stress tests for patients to check for heart
disease, irregular heartbeats and other cardiac-related problems.
Surgical Partners
An increasing number of cardiac nurses are assisting with complex
cardiac procedures in the hybrid operating room, electrophysiology
(EP) lab and catheterization lab. Sentara nurses provide support for
catheter ablations, cardiothoracic surgeries and advanced structural
heart procedures, such as aortic valve repair and replacement.
This surgical collaboration allows for a seamless transition to post-
surgical care during a patient’s recovery. Our nurses also work closely
with patients who have received ventricular assist devices (VADs),
implantable cardioverter defibrillators (ICDs) and pacemakers, as well
as those recovering from heart transplants.
Post-Surgical Intensive Care
In the cardiac surgery intensive care unit (CSICU), cardiac nurses
are part of a multidisciplinary team comprised of cardiologists,
cardiovascular surgeons, nurse practitioners and cardiovascular
perfusionists. The nurses collaborate with heart experts to ensure a
continuum of care for patients who require extracorporeal life support
(ELS), also known as extracorporeal membrane oxygenation (ECMO).
ELS is an emergency stabilizer for patients suffering from acute heart
failure or respiratory failure. This ventricular support system pumps
and oxygenates a patient’s blood in order to give the heart and lungs a
temporary rest. Caring for patients on ELS requires advanced nursing skills. 5352 SENTARA HEART
Cardiac Education Medical education is integral to fulfilling the Sentara mission of improving
health every day. For cardiology specialists at Sentara Heart, this means
extending expertise and knowledge to internal medicine residents and students
at Eastern Virginia Medical School (EVMS) in Norfolk, VA. EVMS shares a
campus with Sentara Norfolk General Hospital (SNGH), which serves as the
medical school’s primary teaching institution.
Medicine, as an instruction guide. The rotation
focuses on both cardiology and medical
reasoning, equipping residents with the
logic and probability tools needed to make a
diagnosis, order appropriate tests, develop
a treatment plan and make a long-term
prognosis.
Each month, a different cardiology expert
from a Sentara hospital prepares and
presents a lecture for EVMS internal medicine
residents and students. Core topics for these
monthly lectures range from congestive heart
failure to atrial fibrillation and hypertension.
SNGH also hosts weekly grand rounds
featuring cardiology experts from world-
renowned medical institutions, such as the
Every year, cardiology experts from Sentara
Heart hospitals volunteer hundreds of hours
of time to educate EVMS internal medicine
residents and students about heart disease
and treatments. Many serve as preceptors to
residents and students, providing one-on-one
guidance and instruction.
Sentara cardiologist John E. Brush Jr., M.D.,
serves as division chief of cardiology for
internal medicine at EVMS and coordinates all
Sentara volunteer cardiac education efforts.
All internal medicine residents at EVMS
complete a mandatory cardiology rotation at
Sentara Leigh Hospital in Norfolk, VA.
Dr. Brush leads this rotation using his well-
respected book, The Science of the Art of
Johns Hopkins University School of Medicine
in Baltimore, MD, and McMaster University
Michael G. DeGroote School of Medicine
in Ontario, Canada. These livestreamed
presentations can be viewed by other
clinicians worldwide.
Sentara Heart also provides postgraduate
training for EVMS advanced practice
clinicians, such as physician assistants and
nurse practitioners. When appropriate,
Sentara Heart physicians collaborate with
EVMS on research projects to improve the
delivery of healthcare to cardiac patients.
55SENTARA HEART54
Recent Areas of Focus and Change Include:
High Reliability Organization:
In 2013, Sentara Heart made a commitment
to change the organization’s culture to be
more reflective of a High Reliability Organization
(HRO). Sentara Heart’s cardiac nurses piloted
this initiative. They recognized that Sentara
already had all of the tools needed to initiate
and sustain this change, most notably
behavior-based safety habits, medical response
teams, daily safety huddles, and patient-
centric care.
The clinical staff worked diligently to promote
the four pillars of an HRO culture: accountability,
leadership, safety and patient-centric care.
Staff then applied the HRO principles to three
targeted safety components that greatly impact
clinical care: out-of-unit codes, catheter-
associated urinary tract infections, and
inpatient falls with injuries.
By 2015, the staff noted remarkable results at
Sentara Heart, and is looking to expand the
HRO program to other Sentara hospital
locations. HRO program results at Sentara
Heart as of October 2015 reflect decreases in:
• Out-of-unit codes: 6 in 2015 vs. 20 in 2014
• Catheter-associated urinary tract
infections: 6 in 2015 vs. 12 in 2014
• Inpatient falls with injury: 11 in 2015 vs.
16 in 2014
Continuing Education:
Many cardiac nurses are taking the
next step into furthering their education
with advanced certifications or degrees,
including doctoral degrees, in various
subspecialties. Sentara Heart continues to
promote continuing education among all
nurses in an effort to transform the care
delivery model. Highly specialized cardiac
nurses bring a significant amount of
intellectual capital to the evidence-based
care they provide every day.
Partners in Research:
Since 2011, Sentara Heart has encouraged
front-line nurses to participate in
research and quality improvement
initiatives by creating a culture of inquiry
and providing logistic support. Every
Friday, researchers from the Sentara
Cardiovascular Research Institute host
a Cardiac Journal Club where nurses
brainstorm possible research or quality
improvement projects with experienced
researchers. The number of nurse-driven
quality improvement projects at Sentara
Heart has increased steadily each year.
In 2015, there were 32 Sentara Heart
presentations, 22 involving cardiac nurses.
Exceptional Patient Care:
The formalized cardiac committees at
Sentara Heart serve as a great platform
for the cardiac nurses. While there are
various types of cardiac nurses working
in multiple settings, there are several
standardized approaches to cardiac care
that are constant among all sites.
Consistency is key and remains a strong
theme among the cardiac nurses. Each
nurse understands the importance of
providing the best care as cost efficiently
as possible. It is for this reason that the
cardiac team is always looking for
collaboration for group purchasing.
The outcome of applying these principles
to the care delivery model, and adhering
to the Sentara Commitments to Cardiac
Nursing Care, is reflected in our customer
service scores. These scores reflect a
rolling 12 months’ percentile ranking
of 96 percent. On a scale of 10 (best
hospital) to 0 (worst hospital), 86 percent
of patients rate their overall care at
Sentara at a 9 or 10.
The Sentara Heart cardiac nurse
embodies the Sentara Philosophy of
Nursing as evidenced by the treatment
provided to patients suffering from heart
conditions. Each patient requires a unique
and individualized treatment approach.
The Sentara Heart nurse delivers a
hallmark standard of care that serves
as a role model for other heart centers
nationwide to emulate.
CARDIAC EDUCATION
Echocardiogram Sonographer Training
Before a Sentara cardiologist can make
a diagnosis, our exceptionally skilled
echocardiogram sonographers use their
expertise in non-invasive technology to
produce clear, readable images of a
patient’s heart.
Approximately 85 sonographers (also
known as echo technicians) work at the 12
Sentara hospital locations. All of the Sentara
echocardiogram labs, including a few that are
located within doctors’ offices, are accredited
by the Intersocietal Accreditation
Commission. Throughout the year,
Sentara sonographers receive training
on best practices to reduce variations
in lab reporting and ensure consistent
standards systemwide.
A new focus for our sonographers
in 2016 was on cardio-oncology and
cardiac strain imaging. Technicians
participated in a hands-on workshop
to learn more about the strain
imaging function available on some
ultrasound machines at various Sentara
hospitals. This ultrasound test captures
information that helps doctors identify early
signs that a heart is under stress or starting to
incur damage. Heart strain is a precursor to
heart failure and congestive heart disease.
Checking for early signs of cardiac disease
is especially important for patients with
cancer undergoing chemotherapy and
radiation because these treatments
can weaken heart muscle. As part
of a newly formed cardio-
oncology program, Sentara
cardiologists work closely
with oncologists to ensure
cancer treatments aren’t
damaging a patient’s
heart. Information from
echocardiograms with
strain imaging enables
cardiologists to more clearly see and identify
subtle changes in heart function. If needed, a
patient’s oncologist can alter treatment before
too much damage occurs.
An education specialist conducts annual
workshops. In 2017, Sentara sonographers will
dissect cow and pig hearts to get an in-depth
look at the heart’s structure and to gain a better
understanding of how the chambers, valves and
arteries interact.
Sonographers also participate in a monthly
guest lecture series presented by various
Sentara heart experts. The annual workshops
and monthly lectures allow sonographers to
earn required continuing medical education
(CME) credits at the same hospital system
where they work.
57SENTARA HEART56
AmuletPrincipal Investigator: Dr. Paul
Mahoney
The AMPLATZER™ Amulet™ Left Atrial
Appendage Occluder (Amulet) is intended
to reduce the risk of thromboembolism
from the left atrial appendage (LAA) in
patients with non-valvular atrial fibrillation.
SurtaviPrincipal Investigators: Drs. Paul
Mahoney and Joseph Newton
To compare the effects of bucindolol
hydrochloride to metoprolol succinate
(Toprol-XL) on the recurrence of
symptomatic atrial fibrillation/atrial
flutter in patients with heart failure who
have a specific genotype for the beta-1
adrenergic receptor.
Enable MRIPrincipal Investigator: Dr. Robert
Bernstein
To confirm the safety and effectiveness
of the ImageReady™ MR Conditional
Defibrillation System when used in the
1.5T MRI environment under the labeled
Conditions of Use.
AXAFAPrincipal Investigator: Dr. Philip
Gentlesk
To demonstrate that anticoagulation with
the direct factor Xa inhibitor apixaban is
not less safe than Vitamin-K-antagonists
(VKA) therapy in patients undergoing
catheter ablation of non-valvular AF
in the prevention of peri-procedural
complications.
Victoria
Principal Investigator: Dr. Wayne Old
This is a randomized, placebo-controlled,
parallel-group, multi-center, double-blind,
event driven trial of MK-1242 (vericiguat)
in subjects with heart failure with reduced
ejection fraction (HFrEF).
Linq HFPrincipal Investigator: Dr. John Herre
The purpose of the LINQ™ HF study is
to characterize Reveal LINQ™ derived
data from patients with heart failure
by assessing the relationship between
changes in LINQ™ derived data and other
physiologic parameters with subsequent
acute decompensated heart failure
(ADHF) events.
As the pre-eminent cardiac research institute
in the mid-Atlantic region, Sentara Heart
works collaboratively with local institutions,
government agencies and biomedical
companies on nationally and internationally
recognized clinical research trials. We focus
our efforts on discovering more effective
cardiovascular treatments and protocols while
eliminating those that are potentially harmful
or not as beneficial. Our ultimate goal is to
provide enhanced clinical care that advances
patient outcomes and improves the overall
health of our community.
Our research touches on every aspect
of heart care, including medical devices,
heart failure, electrophysiology, cardiac
surgery, pulmonary hypertension, cardiac
interventional procedures, structural heart
disease, and the medical management of
coronary artery disease risk factors such as
diabetes and high cholesterol.
Collectively, our research nurses coordinate
more than 80 clinical trials at any given time,
shepherding participants through the entire
trial process, providing care during periods of
need, and tirelessly advocating for their
patients’ well-being.
Sentara Cardiovascular
Research InstituteOver the last decade, the SCRI specialty physician team and uniquely trained
registered nurse research coordinators have made significant strides in
advancing the understanding and treatment of the No. 1 killer in America:
Cardiovascular disease. For more information about current
research trials or questions about SCRI,
please call (757) 388-5480.
Investigational Research Studies at Sentara HeartHere is a sampling of some of the clinical trials active at SCRI in 2016.
59SENTARA HEART58
echocardiography A diagnostic test in which
ultrasonic waves are used to produce images
of the position and motion of the heart and its
internal structures.
ejection fraction The percentage of blood
pumped out of the right and left ventricles
with each heartbeat.
electrophysiology (EP) A branch of cardiology
that deals with the diagnosis and treatment
of heart rhythm disorders. EP doctors
(electrophysiologists) ablate tissue, implant
and manage cardiac devices, and otherwise
care for patients with heart rhythm disorders.
endocarditis Inflammation of the lining of the
heart and valve leaflets.
extracorporeal membrane oxygenation (ECMO)
The technique of providing both cardiac
and respiratory support (oxygen) to patients
whose heart and lungs are so severely
diseased or damaged that they can no longer
function. Other variations of its capabilities
have been tested and used over the last few
years, making it an important tool in life and
organ support (extracorporeal circuitry). With
all of these uses, a new term, extracorporeal
life support (ECLS), is now commonly used to
describe this technology.
femoral artery A large artery in the thigh that
connects to the aorta.
implantable cardioverter defibrillators A small
device that’s placed in the chest or abdomen
to help treat irregular heartbeats called
arrhythmias. An ICD uses electrical pulses
or shocks to help control life-threatening
arrhythmias, especially those that can cause
sudden cardiac arrest.
inoperable Unsuitable for a surgical procedure.
lipid A group of naturally occurring molecules
that include fats, waxes, sterols, and fat-soluble
vitamins.
mitral valve The only bi-leaflet valve in the
heart, it regulates the flow of blood from the left
ventricle to the left atrium.
mitral valve repair A surgical procedure to
treat the narrowing (stenosis) or leakage
(regurgitation) of the mitral valve – the “inflow
valve” for the left side of the heart.
myocardial biopsies The removal of a small
piece of heart muscle for examination.
myocardial infarction Otherwise known as a
heart attack, this occurs when blood vessels
that supply blood to the heart are blocked,
preventing enough oxygen from getting to
the heart. The heart muscle dies or becomes
permanently damaged.
myocardium The fibrous muscle tissue of
the heart.
palpitations A rapid or irregular heartbeat.
patent foramen ovale (PFO) A “hole” in the
heart that is often harmless. About 1 in 5
Americans have PFO. Many don’t know it until
a medical condition like a stroke or mini stroke
occurs. PFOs often have no symptoms but they
increase your risk for stroke.
pericardial tissue The tough, protective sac
surrounding the heart.
GLOSSARY
We have provided this glossary for those readers
who may not be as familiar with some of the
medical terms used in this annual report.
atrial septal defect (ASD) A form of congenital
heart defect that enables blood flow between
two compartments of the heart and can lead to
lower-than-normal oxygen levels in the arterial
blood that supplies the brain, organs and
tissues. However, an ASD may not produce
noticeable signs or symptoms, especially if the
defect is small.
balloon valvuloplasty A procedure performed
to open a narrowed heart valve using a thin
tube called a catheter with a small balloon at
its tip. The catheter is inserted through a small
incision in the groin and then threaded up to
the opening of the narrowed heart valve. The
balloon is then inflated to stretch the valve
open and relieve valve obstruction.
bi-leaflet A valve that has two leaflets that
regulate the flow of blood. A normal aortic
valve has three leaflets.
calcification A disease state in which calcium
from the blood collects in the body tissues.
When this occurs on the leaflets of the heart’s
valves, it may cause them to harden and
reduce their ability to open and close properly.
cardiac ablations A procedure that can correct
heart rhythm problems, typically using long,
flexible tubes inserted through a vein in the
groin (or wrist) and threaded to the heart to
correct structural problems. Cardiac ablation
works by scarring or destroying tissue in the
heart that triggers an abnormal heart rhythm.
cardiac catheterization Cardiac catheterization
is a minimally invasive procedure commonly
used to diagnose and treat heart conditions.
During catheterization, small tubes (catheters)
are inserted into the circulatory system to
determine if there are obstructions within
the blood vessels that feed the heart.
cardiopulmonary bypass (CPB) Bypass of
the heart and lungs. During this technique,
which is often used during heart surgery, a
heart-lung machine temporarily takes over
the function of the heart and lungs.
catheterization A procedure in which a
thin tube called a catheter is inserted
into the body.
comorbidity The presence of one or more
additional disorders or diseases that occur
at the same time as a primary disease or
disorder.
congestive heart failure A condition in
which the heart cannot pump enough blood
to the body’s other organs.
coronary artery disease A narrowing of the
small blood vessels that supply blood and
oxygen to the heart.
echocardiogram (ECHO) A test that uses
sound waves to produce live images of your
heart, allowing your doctor to monitor how
your heart and its valves are functioning.
An echo can help spot blood clots in the
heart, fluid in the sac around the heart, and
problems with the aorta.
echocardiogram (EKG) A test that checks for
problems with the electrical activity of your
heart and translates the heart’s electrical
activity into line tracings – spikes and dips,
called waves – on paper.
OF TERMS
angina Chest pain that occurs when an area
of the heart muscle does not receive enough
oxygen-rich blood.
aorta The largest artery in the body, it receives
blood from the heart that has been oxygenated
in the lungs, and delivers this blood to the body
and brain.
aortic stenosis A progressive disease that
affects the aortic valve of the heart.
aortic valve The heart valve that regulates the
one-way flow of blood from the left ventricle to
the aorta.
arteries Blood vessels that carry blood away
from your heart to other parts of your body.
atria The two upper chambers of the heart that
receive blood returning from the body.
atrial fibrillation Atrial fibrillation, or AF, is the
most common type of heart rhythm disorder
(arrhythmia). During an arrhythmia, the heart
can beat too fast, too slow, or with an irregular
rhythm. AF occurs if rapid, disorganized
electrical signals cause the heart’s two upper
chambers (the atria) to contract very quickly
and irregularly (fibrillate).
61SENTARA HEART60
2016 Sentara Heart Annual Report
The CARE Unit (cardiac assessment, recovery and evaluation) at Sentara Heart Hospital “always says yes!”
to referring providers wanting to transfer or admit cardiac patients to our care. Over the last few years,
Sentara Heart Hospital has experienced a 36 percent increase in patient transfers and referrals. The hospital
will not turn away a cardiac patient in need.
In 2016, Sentara Heart collaborated with Sentara’s Regional Transfer Center to coordinate efforts to transfer
cardiac patients. All patients are transferred with the underlying principle of “Right place, right time and the
right level of care.” Our one-call-does-it-all system allows a referring or accepting physician to focus on the
patient instead of arranging and coordinating transfers.
The process is quite seamless as the CARE Unit uses the Regional Transfer Center’s teletracking system to
view all patients awaiting transfer:
• Once Sentara Heart Hospital receives a transfer request, an expert CARE Unit team member gathers
information about the patient’s clinical needs and relays the details to a Sentara Heart doctor.
• Sentara’s doctors and the CARE Unit evaluate the patient’s clinical needs and determine the best
mode of transportation, either via ambulance or Nightingale Regional Air Ambulance.
• Depending on the patient’s status, the CARE Unit prepares the required procedure room—
ICU, cath lab, operating room, CARE unit, stepdown or other.
• A member of the CARE Unit team notifies the referring physician of the action plan
and serves as the central point of contact throughout the patient transfer and for all
status updates.
The CARE Unit at Sentara Heart Hospital on the campus of Sentara Norfolk General
Hospital serves as the portal for entry, preparation and recovery for catheterizations,
electrophysiology (EP) and cardiac operating room procedures. This system provides
seamless coordination of cardiac care and ensures that Sentara Heart is prepared to meet
a patient’s level of care before arrival.
Transferring a Patient to Sentara Heart Hospitalpercutaneous coronary intervention (PCI) A
procedure more commonly known as coronary
angioplasty that is used to treat the narrowed
(stenotic) coronary arteries of the heart found
in coronary heart disease. These narrowed
segments are due to plaque buildup.
perioperative The time period describing the
duration of a patient’s surgical procedures
from check-in through recovery—
preoperative, intraoperative, and
postoperative.
peripheral vascular disease (PVD) A slow and
progressive circulation disorder. It may involve
disease in any of the blood vessels outside of
the heart or in the arteries, veins, or lymphatic
vessels. Organs supplied by these vessels, such
as the brain, heart, and legs, may not receive
adequate blood flow. The legs and feet are
most commonly affected.
pressure ulcers Also known as bedsores,
pressure ulcers are localized injuries to the skin
and/or underlying tissue that usually occur over
a prominence as a result of pressure or friction.
pulmonary arterial hypertension (PAH) An
increase of blood pressure in the pulmonary
arteries. These arteries carry blood from your
heart to your lungs to pick up oxygen. PAH
causes symptoms such as shortness of breath,
dizziness, fainting, chest pain, and leg swelling.
As the condition worsens, its symptoms may
limit all physical activity.
pulmonary valve The valve that regulates the
flow of blood from the pulmonary artery to the
right ventricle.
regurgitation The backward flow of blood
(in the opposite direction than it would
normally flow).
stenosis The narrowing of an opening.
stents A small mesh tube that’s used to treat
narrow or weak arteries.
syncopy A loss of consciousness, or
fainting, caused by a temporary lack of
oxygen to the brain.
ST-segment elevation myocardial infarction
(STEMI) A type of heart attack that occurs
when a coronary artery suddenly becomes
at least partially blocked by a blood clot,
causing at least some of the heart muscle
being supplied by that artery to die.
telemanagement Advanced technology
that enables doctors and nurses to monitor
patients remotely.
transcatheter aortic valve replacement (TAVR)
(also referred to as TAVI or transcatheter
aortic valve implantation): A treatment
option for inoperable patients that allows
doctors to replace a heart valve using a
catheter put into a small cut – avoiding the
need for open-heart surgery.
transesophageal echocardiogram (TEE) A
type of echo test that provides a close look
at the heart’s valves and chambers, without
interference from the ribs or lungs. During
a TEE, an ultrasound transducer, positioned
on an endoscope, is guided down a
patient’s throat into the esophagus.
tricuspid valve The heart valve that regulates
the flow of blood from the right ventricle to
the right atrium.
tricuspid valve repair The tricuspid valve
is located between the heart’s right upper
chamber (atrium) and lower chamber
(ventricle). Its role is to make sure blood flows
the correct way through the heart. In some
people, this valve does not function correctly
(tricuspid valve disease). The valve can be
repaired (preferred) or replaced.
tri-leaflet A valve with three leaflets. A
normal aortic valve is a tri-leaflet valve.
valve leaflets Flaps of tissue that open and
close to help regulate the flow of blood in one
direction through the valve.
valvuloplasty A procedure in which a catheter
is advanced from a blood vessel in the groin
through the aorta into the heart. A large
balloon at the tip of the catheter is inflated
until the flaps of the valve are opened. Once
the valve has opened, the balloon is deflated
and the catheter is removed. Valvuloplasty
is performed in certain situations in order to
open a heart valve that has become stiff.
veins The blood vessels that return
de-oxygenated blood to the heart and lungs.
ventricles The large, lower blood-pumping
chambers of the heart.
GLOSSARY OF TERMS
62 63SENTARA HEART
AnnualReport.SentaraHeart.com